Diplopia

H7_DIPLOPIA

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H53.2 Hospital discharge: ICD-9 — 3682 Cause of death: ICD-10 — H53.2 Cause of death: ICD-9 — 3682 2 out of 7 registries used, show all original rules.	6496
4. Check minimum number of events None	6496
5. Include endpoints None	6496
6. Filter based on genotype QC (FinnGen only)	5824

Control definitions (FinnGen only)

Control exclude: H7_VISUALDISTBLIND

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: H53
Name in latin: Diplopia

NAME	H7_DIPLOPIA
CONTROL_EXCLUDE	H7_VISUALDISTBLIND
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H532
HD_ICD_9	3682
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H532
COD_ICD_9	3682
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Diplopia based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	31915	16114	15679
Only index persons	29817	15235	14582
Unadjusted period prevalence (%)
Whole population	0.45	0.46	0.44
Only index persons	0.56	0.56	0.56
Median age at first event (years)
Whole population	58.10	57.83	58.33
Only index persons	57.67	57.47	57.89

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	5824	3231	2593
Unadjusted period prevalence (%)	1.17	1.15	1.19
Median age at first event (years)	59.86	56.89	63.55

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
6039: Matched controls
60390

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

H49.1

ICD-10 Finland

Fourth [trochlear] nerve palsy

52.1

307.7

335

H49.2

ICD-10 Finland

Sixth [abducent] nerve palsy

57.8

307.7

538

102

H50.2

ICD-10 Finland

Vertical strabismus

29.8

307.7

303

107

XCK00

NOMESCO Finland

Perimetry

5.4

307.7

774

1610

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

5.3

307.7

1138

2546

H49.0

ICD-10 Finland

Third [oculomotor] nerve palsy

36.7

307.7

233

H53.2

ICD-10 Finland

Diplopia

64359.6

307.7

5993

122

AA1AD

NOMESCO Finland

CT of head and brain

3.8

307.7

2893

11816

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

4.8

307.7

1190

2911

Z01.0

ICD-10 Finland

Examination of eyes and vision

3.3

307.7

1732

6506

H53.1

ICD-10 Finland

Subjective visual disturbances

13.9

307.7

905

756

XCW99

NOMESCO Finland

Other investigative procedure of eye

5.0

307.7

1409

3474

H50.52

ICD-10 Finland

Exophoria

17.2

307.7

287

175

CE2W4

NOMESCO Finland

Eye movement mapping

100.4

284.0

147

H53.4

ICD-10 Finland

Visual field defects

37.2

274.1

170

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

6.6

262.8

439

706

TAB00

NOMESCO Finland

Lumbar puncture

5.4

259.1

544

1089

R51.80

ICD-10 Finland

Headache

3.0

253.4

1396

5493

R42

ICD-10 Finland

Dizziness and giddiness

2.6

242.2

1937

9223

H53.9

ICD-10 Finland

Visual disturbance, unspecified

7.2

236.8

363

532

H50.0

ICD-10 Finland

Convergent concomitant strabismus

18.7

229.7

183

101

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.5

217.4

830

2605

N07AA02

ATC

pyridostigmine; systemic

19.9

213.6

165

G70.0

ICD-10 Finland

Myasthenia gravis

23.9

205.3

147

H50.31

ICD-10 Finland

Intermittent exotropia

15.5

199.5

174

115

G35

ICD-10 Finland

Multiple sclerosis

8.9

196.6

249

291

CEC10

NOMESCO Finland

Recession and resection of extraocular muscle

15.8

195.3

169

110

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

4.8

194.1

468

1049

H50.51

ICD-10 Finland

Esophoria

22.3

193.2

142

CEC00

NOMESCO Finland

Recession of extraocular muscle

26.7

171.9

118

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.1

168.8

3303

22037

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

3.0

168.1

869

3244

F05

ICPC

Visual disturbance other

5.0

167.5

371

773

108

Kela drug reimbursment

Myasthenia gravis

25.7

166.6

116

303

Kela drug reimbursment

Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)

11.5

165.3

172

153

H50.1

ICD-10 Finland

Divergent concomitant strabismus

13.9

164.8

153

113

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

3.0

163.2

832

3079

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

14.1

159.7

147

107

H50.30

ICD-10 Finland

Intermittent esotropy

24.5

159.5

113

157

Kela drug reimbursment

Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)

11.8

158.7

163

142

109

Kela drug reimbursment

Multiple sclerosis

9.8

157.0

184

194

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

3.1

153.6

693

2388

H06.2*E05.9

ICD-10 Finland

Dysthyroid exophthalmos

14.2

144.3

132

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

5.3

142.3

293

572

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

6.0

132.8

241

418

PA6AD

NOMESCO Finland

CT of neck arteries

4.1

127.1

372

963

N03AX09

ATC

lamotrigine; oral

3.6

118.4

408

1183

N03AX12

ATC

[U] gabapentin; oral

2.2

117.3

1167

5871

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

4.0

115.0

344

904

B01AC04

ATC

clopidogrel; oral

2.2

111.3

1176

6048

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

3.0

110.2

523

1844

N03AX16

ATC

[U] pregabalin

2.0

109.9

1570

9025

G44.2

ICD-10 Finland

Tension-type headache

2.3

109.1

971

4652

XA800

NOMESCO Finland

Neuropsychological investigation

3.6

106.6

368

1067

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.8

99.6

2717

19032

H53.3

ICD-10 Finland

Other disorders of binocular vision

23.9

99.4

N02AX02

ATC

tramadol; systemic, rectal

1.8

98.9

2731

19185

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

3.0

98.0

463

1625

H50.9

ICD-10 Finland

Strabismus, unspecified

20.5

96.0

H04.10

ICD-10 Finland

Dry eye syndrome

2.3

94.4

845

4042

G37.9

ICD-10 Finland

Demyelinating disease of central nervous system, unspecified

10.3

93.6

105

104

Z3231

NOMESCO Finland

Registered nurse

1.8

92.7

1773

11115

S06.0

ICD-10 Finland

Concussion

2.3

91.0

786

3700

CA1BG

NOMESCO Finland

Eye and orbita MRI examination with high intensity magnet

15.0

90.4

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.6

89.2

563

2298

R06.0

ICD-10 Finland

Dyspnoea

1.8

88.3

1794

11425

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

3.7

86.7

289

817

A02BC02

ATC

pantoprazole; systemic

1.8

86.4

4206

34087

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.9

86.0

1259

7218

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.4

84.7

634

2800

S02.30

ICD-10 Finland

Fracture of orbital floor, closed

7.4

84.6

123

169

L03AB07

ATC

interferon beta-1a; parenteral

10.3

81.2

CEC60

NOMESCO Finland

Transposition of extraocular muscle with adjustable suture

47.4

80.1

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

80.1

2267

15763

L03AX13

ATC

glatiramer acetate; parenteral

12.3

79.6

R53

ICD-10 Finland

Malaise and fatigue

1.8

79.4

1637

10412

CA1CM

NOMESCO Finland

Eye and orbita extensive MRI examination with 3 Tesla magnet

22.5

79.2

CS494

NOMESCO Finland

Other visual field testing

4.0

79.1

228

582

N17

ICPC

Vertigo/dizziness

2.1

78.3

905

4760

R20.2

ICD-10 Finland

Paraesthesia of skin

2.5

77.5

520

2181

CEC30

NOMESCO Finland

Resection of extraocular muscle

37.2

77.3

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

77.0

1805

11892

XF400

NOMESCO Finland

ECG with 12 standard connections

2.0

76.9

1011

5564

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.6

76.9

467

1866

H51.1

ICD-10 Finland

Convergence insufficiency and excess

16.6

76.2

H50.8

ICD-10 Finland

Other specified strabismus

23.7

75.2

H55

ICD-10 Finland

Nystagmus and other irregular eye movements

13.3

75.0

H02AB06

ATC

prednisolone; systemic

1.6

74.9

2903

21776

N06AX16

ATC

venlafaxine; oral

2.0

72.9

902

4853

PA6BG

NOMESCO Finland

MRI examination of neck vasculature with high intensity magnet

9.4

72.8

N03AG01

ATC

valproic acid; systemic, rectal

2.7

71.8

418

1634

M79.6

ICD-10 Finland

Pain in limb

1.6

71.7

2683

19879

N02BE01

ATC

paracetamol; systemic, rectal

2.2

71.6

5415

48395

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

71.5

1451

9141

H57.1

ICD-10 Finland

Ocular pain

3.1

70.7

309

1034

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.8

70.3

368

1362

G43.9

ICD-10 Finland

Migraine, unspecified

2.7

70.1

411

1612

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

69.5

1801

12126

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

6.0

69.5

123

208

N06AX11

ATC

mirtazapine; oral

1.7

68.7

2073

14513

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.7

68.7

1966

13579

H53.8

ICD-10 Finland

Other visual disturbances

6.3

68.3

115

185

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

4.8

67.2

154

329

H46

ICD-10 Finland

Optic neuritis

8.2

66.1

109

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

4.2

64.8

176

430

R02

ICPC

Shortness of breath/dyspnoea

1.9

64.6

902

5042

N06AX21

ATC

duloxetine; oral

2.0

64.3

768

4069

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

5.0

64.1

140

287

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

2.5

64.0

448

1912

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.9

63.8

908

5107

X59

ICD-10 Finland

Exposure to unspecified factor

1.8

63.6

1197

7344

PA6AG

NOMESCO Finland

Limited MRI examination of neck vasculature with high intensity magnet

8.9

63.5

M54.5

ICD-10 Finland

Low back pain

1.6

63.3

2207

15928

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

62.4

1375

8817

H52.5

ICD-10 Finland

Disorders of accommodation

24.6

62.1

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.8

61.6

1078

6466

N03AF02

ATC

oxcarbazepine; oral

3.2

61.0

254

826

N01

ICPC

Headache

2.0

60.8

715

3763

L04AX07

ATC

dimethyl fumarate; oral

12.7

60.6

E05.0

ICD-10 Finland

Thyrotoxicosis with diffuse goitre

3.3

58.5

225

697

H02.4

ICD-10 Finland

Ptosis of eyelid

3.2

58.5

237

758

G51.0

ICD-10 Finland

Bell palsy

3.3

58.2

220

674

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.5

58.1

381

1576

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

6.9

58.0

133

164

Kela drug reimbursment

Fingolimod

13.6

57.9

H53.0

ICD-10 Finland

Amblyopia ex anopsia

14.1

57.9

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

57.7

2560

19414

A04

ICPC

Weakness/tiredness general

1.8

57.5

1029

6200

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.7

57.4

332

1292

S18

ICPC

Laceration/cut

1.5

57.2

2843

22094

F29

ICPC

Eye symptom/complaint other

2.0

57.1

683

3611

H06.2

ICD-10 Finland

Dysthyroid exophthalmos

18.9

57.0

H54.2

ICD-10 Finland

Moderate visual impairment, binocular

18.9

57.0

N05AH04

ATC

quetiapine; oral

1.8

56.9

1061

6471

N86

ICPC

Multiple sclerosis

7.4

56.7

112

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

5.4

56.2

112

212

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.9

55.9

778

4330

N02BF01

ATC

gabapentin; oral

2.0

55.5

683

3646

CAC10

NOMESCO Finland

Reconstruction of orbital wall using bone graft or plate

13.9

55.3

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.0

55.3

668

3543

R4110

NOMESCO Finland

Physiotherapy

1.6

55.1

1665

11527

N03AE01

ATC

clonazepam; systemic

2.4

55.1

386

1646

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.8

54.9

995

6012

Z3229

NOMESCO Finland

Other healthcare associate professional

2.1

54.3

532

2611

C10AA05

ATC

atorvastatin; oral

1.5

54.0

2498

19030

UKC02

NOMESCO Finland

Cystoscopy

1.8

53.7

999

6079

L03AB08

ATC

interferon beta-1b; parenteral

14.1

53.6

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.0

53.5

682

3684

3682A

ICD-9 Finland

Visual disturbances, Diplopia

+∞

53.2

H05.2

ICD-10 Finland

Exophthalmic conditions

13.3

52.8

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.5

52.6

358

1505

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.3

52.6

414

1857

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

52.0

1519

10404

C07AB07

ATC

bisoprolol; oral

1.5

51.8

2849

22447

H50.4

ICD-10 Finland

Other and unspecified heterotropia

22.5

51.8

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

51.7

2549

19627

A28

ICPC

Limited function/disability NOS

1.7

51.5

1129

7182

L04AA27

ATC

[U] fingolimod

15.8

51.2

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.7

51.1

1082

6817

A02BC05

ATC

esomeprazole; systemic

1.5

51.1

2349

17809

Z2445

NOMESCO Finland

Psychologist

2.8

50.9

255

920

R13

ICD-10 Finland

Dysphagia

2.1

50.3

484

2357

M54.4

ICD-10 Finland

Lumbago with sciatica

1.7

50.2

1087

6887

Z3226

NOMESCO Finland

Physiotherapist

1.7

50.0

1071

6766

N05CF01

ATC

zopiclone; oral

1.6

50.0

1853

13391

C07AA05

ATC

propranolol; systemic

1.7

49.8

1151

7420

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.2

49.7

463

2226

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.1

49.3

500

2484

PA7BD

NOMESCO Finland

CT angiography of neck and brain

4.1

49.3

138

345

R55

ICD-10 Finland

Syncope and collapse

1.9

49.0

702

3935

J01DB01

ATC

cefalexin; oral

1.6

48.9

4869

43293

L28

ICPC

Limited function/disability (L)

1.7

48.9

1181

7696

N03AX11

ATC

topiramate; oral

3.4

48.9

175

518

R03AC02

ATC

salbutamol; inhalant

1.5

48.9

3142

25438

L03

ICPC

Low back symptom/complaint

1.6

48.9

1734

12395

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.6

48.7

303

1221

353

Kela drug reimbursment

Cladribine and fingolimod

12.8

48.6

ZXA10

NOMESCO Finland

Bilateral

1.7

48.5

1089

6962

M25.5

ICD-10 Finland

Pain in joint

1.5

48.2

1914

14017

L17

ICPC

Foot/toe symptom/complaint

1.5

48.2

1829

13264

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.4

48.1

337

1435

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

47.7

4168

35844

R51

ICD-10 Finland

Headache

2.4

47.5

359

1581

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.7

47.4

270

1042

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

47.4

1965

14516

N06AB04

ATC

citalopram; systemic

1.6

46.8

1188

7831

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

46.6

830

4970

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

46.5

1331

9035

XCK10

NOMESCO Finland

Photography of fundus of eye

2.0

46.5

580

3103

A01

ICPC

Pain general/multiple sites

1.9

46.4

644

3569

H50.50

ICD-10 Finland

Alternating hyperphoria

17.4

46.3

A11

ICPC

Chest pain NOS

2.0

46.0

555

2934

M03BX01

ATC

baclofen; systemic

3.6

45.9

154

437

M03BX02

ATC

tizanidine; oral

1.5

45.9

3480

28955

N05BA04

ATC

oxazepam; oral

1.6

45.8

1517

10649

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

45.8

780

4608

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

45.6

1132

7413

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.9

45.6

606

3310

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

45.2

1526

10754

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

45.1

2385

18472

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

44.6

2016

15119

J01MA02

ATC

ciprofloxacin; systemic

1.5

44.5

2234

17111

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

4.5

44.2

107

239

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

44.2

1092

7138

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.7

44.1

847

5176

R52.9

ICD-10 Finland

Pain, unspecified

1.9

44.1

637

3574

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.3

44.0

352

1589

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

3.2

44.0

178

569

R52.2

ICD-10 Finland

Other chronic pain

2.6

43.4

259

1023

N02AA05

ATC

oxycodone; systemic

1.6

42.9

1101

7259

ZXD05

NOMESCO Finland

Urgent procedure

1.5

42.7

1686

12267

C03CA01

ATC

furosemide; systemic

1.5

42.4

1742

12776

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

42.3

1667

12121

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

3.4

42.2

155

467

R4120

NOMESCO Finland

Occupational therapy

2.1

42.0

410

2004

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.8

42.0

655

3762

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

2.6

41.7

250

989

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.1

41.7

177

582

H062, E050,

ICD-10 Finland

14.2

41.6

N06AB10

ATC

escitalopram; oral

1.6

41.3

1131

7571

R50.9

ICD-10 Finland

Fever, unspecified

1.7

41.1

909

5766

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

41.0

1051

6921

N06AB03

ATC

fluoxetine; oral

1.8

40.9

693

4079

R11

ICD-10 Finland

Nausea and vomiting

1.9

40.9

544

2970

UJF32

NOMESCO Finland

Coloscopy

1.5

40.9

1506

10780

XCD10

NOMESCO Finland

Electrophysiological examination of eye

3.2

40.6

160

503

H47.2

ICD-10 Finland

Optic atrophy

11.8

40.3

N05BA01

ATC

diazepam; systemic, rectal

1.7

40.1

741

4471

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

39.9

3093

25541

ZYC01

NOMESCO Finland

Remote contact by phone

2.1

39.6

392

1927

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

2.9

39.3

194

695

H03AA01

ATC

levothyroxine sodium; systemic

1.6

39.2

1296

9046

N30.0

ICD-10 Finland

Acute cystitis

1.6

39.1

1004

6605

Z2446

NOMESCO Finland

Social worker

2.1

38.8

384

1886

D32.02

ICD-10 Finland

Benign tumor of the meninges at the base of the brain

5.2

38.7

153

N03AF01

ATC

carbamazepine; oral, rectal

2.3

38.6

305

1368

SPAT1263

SPAT

Sampling

1.4

38.6

2343

18463

N06AA09

ATC

amitriptyline; systemic

1.9

38.5

555

3106

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.7

38.5

709

4273

R07.3

ICD-10 Finland

Other chest pain

1.8

38.4

615

3556

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

38.3

2950

24256

Z71.8

ICD-10 Finland

Other specified counselling

1.5

38.2

1935

14732

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

38.2

1368

9709

WX892

NOMESCO Finland

Monitored bed care

2.0

38.2

461

2434

ZXA05

NOMESCO Finland

Left side

1.5

38.2

1349

9548

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

38.1

792

4935

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

38.0

1062

7128

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.2

37.9

329

1535

H02AB07

ATC

prednisone; oral

1.7

37.8

775

4808

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.6

37.5

229

914

W19

ICD-10 Finland

Unspecified fall

1.8

37.4

596

3441

L12

ICPC

Hand/finger symptom/complaint

1.6

37.3

1011

6731

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.4

37.3

259

1098

N03AX14

ATC

levetiracetam; systemic

2.8

37.3

196

726

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.7

37.1

730

4477

G47.3

ICD-10 Finland

Sleep apnoea

1.5

37.0

1305

9225

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

36.9

2127

16563

K59.09

ICD-10 Finland

Constipation, unspecified

2.0

36.9

446

2355

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

4.0

36.9

105

266

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

3.1

36.9

155

507

WX002

NOMESCO Finland

Sedation and analgesia

1.6

36.8

1083

7351

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

5.5

36.7

131

G45.3

ICD-10 Finland

Amaurosis fugax

3.6

36.5

121

341

SPAT1301

SPAT

No procedures

1.5

36.5

1751

13169

N05AX12

ATC

aripiprazole; systemic

2.5

36.4

236

969

JN3AD

NOMESCO Finland

Abdominal CT examination

1.7

36.3

793

5001

D01

ICPC

Abdominal pain/cramps general

1.7

36.2

717

4405

A02BC01

ATC

omeprazole; systemic

1.5

36.1

1518

11118

N04BC05

ATC

pramipexole; oral

1.9

36.0

458

2460

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.3

35.8

273

1207

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

35.7

624

3701

T90.5

ICD-10 Finland

Sequelae of intracranial injury

4.2

35.3

231

J01FF01

ATC

clindamycin; systemic

1.5

35.1

1499

11004

J01AA02

ATC

doxycycline; systemic

1.5

35.1

4405

39212

PA2AD

NOMESCO Finland

CT angiography of brain

4.6

34.7

180

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.7

34.5

796

5086

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

3.3

34.5

134

418

2AB04, ,

NOMESCO Finland

10.1

34.5

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.5

34.3

214

863

A03FA01

ATC

metoclopramide; systemic, rectal

1.5

34.3

1234

8741

R05

ICPC

Cough

1.5

34.2

1413

10295

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

34.1

915

6066

GEC24

NOMESCO Finland

Thoracoscopic thymectomy

13.4

33.9

P03

ICPC

Feeling depressed

1.8

33.9

550

3190

H52.2

ICD-10 Finland

Astigmatism

3.2

33.9

134

423

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

33.8

4040

35489

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

33.6

1569

11705

H54.7

ICD-10 Finland

Unspecified visual loss

6.8

33.5

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

33.4

2140

16907

CEW99

NOMESCO Finland

Other operation on extraocular muscle

38.5

33.4

R06AE07

ATC

cetirizine; oral

1.4

33.3

2408

19419

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

3.3

33.3

126

387

A06AD11

ATC

lactulose; oral

1.6

33.2

837

5465

L01

ICPC

Neck symptom/complaint

1.6

33.2

919

6137

G81.9

ICD-10 Finland

Hemiplegia, unspecified

4.2

33.1

208

H03BB01

ATC

carbimazole; oral

2.3

33.0

256

1139

A02BC03

ATC

lansoprazole; oral

1.5

32.9

1542

11502

PA6CG

NOMESCO Finland

Extensive MRI examination of neck vasculature with high intensity magnet

8.1

32.8

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

3.9

32.8

244

R60.0

ICD-10 Finland

Localized oedema

1.6

32.7

752

4797

J01EA01

ATC

trimethoprim; systemic

1.5

32.7

1400

10259

R01AD09

ATC

mometasone; nasal

1.4

32.7

2463

19981

M79.1

ICD-10 Finland

Myalgia

1.6

32.6

838

5495

Z2221

NOMESCO Finland

Medical doctor

1.5

32.5

1472

10901

N02BF02

ATC

pregabalin; oral

1.9

32.5

415

2231

ZXE00

NOMESCO Finland

One hour or less

1.4

32.3

2098

16586

N06AB06

ATC

sertraline; oral

1.7

32.3

624

3801

H52.1

ICD-10 Finland

Myopia

2.5

32.2

215

895

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

32.2

735

4680

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.8

32.1

563

3338

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

32.1

1362

9958

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.5

32.0

1455

10781

PA7CD

NOMESCO Finland

CT angiography of neck and brain, extensive

4.2

31.9

205

SPAT1240

SPAT

Therapeutic discussion

1.8

31.9

551

3252

ZY010

NOMESCO Finland

Hospital outpatient

2.1

31.9

299

1438

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.8

31.7

544

3204

CS5Z4

NOMESCO Finland

Specialised imaging for glaucoma

2.8

31.7

160

580

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.3

31.7

256

1159

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

31.6

1083

7577

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.5

31.5

204

838

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

4.4

31.5

178

PA2CC

NOMESCO Finland

Cerebral very extensive angiography with X-ray

5.1

31.3

128

U02

ICPC

Urinary frequency/urgency

1.6

31.1

839

5562

P76

ICPC

Depressive disorder

1.9

30.5

376

1996

K02.1

ICD-10 Finland

Caries of dentine

1.4

30.4

3255

27822

XKD00

NOMESCO Finland

Uroflowmetry

1.6

30.3

880

5931

G04BD12

ATC

mirabegron; oral

1.6

30.2

704

4500

G43.3

ICD-10 Finland

Complicated migraine

3.3

30.2

112

340

WX402

NOMESCO Finland

General anaesthesia

1.5

30.1

1230

8913

R51.81

ICD-10 Finland

Facial pain NOS

2.7

30.0

159

592

SPAT1260

SPAT

Consultation of another employee

1.5

29.8

957

6592

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

29.8

775

5091

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

29.7

2027

16100

XF404

NOMESCO Finland

Ambulatory ECG

1.8

29.7

487

2829

Q28.3

ICD-10 Finland

Other malformations of cerebral vessels

7.5

29.7

SPAT1097

SPAT

Recording of ECG

1.6

29.5

801

5311

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

29.5

1308

9621

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.8

29.5

485

2820

C10AA01

ATC

simvastatin; oral

1.4

29.5

2259

18284

183

Kela drug reimbursment

Lamotrigin and topiramate

4.6

29.3

151

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.6

29.3

697

4477

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.5

29.3

186

757

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.5

29.3

1238

9024

J01CA04

ATC

amoxicillin; systemic

1.4

29.2

4664

42430

X58

ICD-10 Finland

Exposure to other specified factors

1.6

29.1

812

5417

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.9

29.1

376

2027

U07

ICPC

Urine symptom/complaint other

1.8

29.1

504

2974

R00.2

ICD-10 Finland

Palpitations

1.8

29.1

445

2531

P29

ICPC

Psychological sympt/compl other

1.9

29.1

412

2288

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.7

29.1

589

3629

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

29.1

662

4205

L08

ICPC

Shoulder symptom/complaint

1.5

29.1

1292

9505

H26.4

ICD-10 Finland

After-cataract

1.7

28.9

571

3496

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.4

28.9

1423

10670

N28

ICPC

Limited function/disability (N)

3.0

28.8

126

422

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

28.7

1656

12769

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.8

28.6

450

2581

F31.8

ICD-10 Finland

Other bipolar affective disorders

3.1

28.6

118

382

N05AH03

ATC

olanzapine; systemic

1.9

28.6

349

1847

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

4.1

28.4

193

R35

ICD-10 Finland

Polyuria

1.8

28.3

411

2302

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.4

28.2

189

789

R4110, ,

SPAT

1.6

28.2

770

5112

R1250

NOMESCO Finland

Evaluation of functional capability

2.6

28.2

166

652

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.7

28.2

513

3071

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.7

28.1

535

3243

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.5

28.0

185

767

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

28.0

1724

13433

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.4

27.9

1798

14114

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

3.2

27.8

112

358

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.1

27.8

286

1425

H50.6

ICD-10 Finland

Mechanical strabismus

32.9

27.7

H02AB09

ATC

hydrocortisone; systemic

2.7

27.7

150

565

D11

ICPC

Diarrhoea

1.6

27.7

654

4192

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.6

27.6

162

635

P01AB01

ATC

metronidazole; oral, rectal

1.4

27.6

2103

16958

H01

ICPC

Ear pain/earache

1.6

27.5

644

4118

B01AB05

ATC

enoxaparin; parenteral

1.4

27.5

1716

13392

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

3.0

27.5

120

402

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.7

27.4

526

3193

R5110, ,

SPAT

1.7

27.4

506

3040

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

3.5

27.4

267

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

2.0

27.3

297

1509

N18

ICPC

Paralysis/weakness

2.8

27.3

136

490

DFF00

NOMESCO Finland

Pure tone audiometry

1.7

27.3

582

3634

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

27.2

1054

7536

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

3.0

27.2

123

420

D06

ICPC

Abdominal pain localized other

1.7

27.1

501

3010

Z01.2

ICD-10 Finland

Dental examination

1.3

27.1

2523

20964

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

27.1

2491

20659

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

3.7

26.9

237

D32.00

ICD-10 Finland

Benign tumor of the meninges on the outer surface of the cerebrum

3.4

26.8

285

H50.59

ICD-10 Finland

Heterophor UNS

27.8

26.6

H51.2

ICD-10 Finland

Internuclear ophthalmoplegia

27.8

26.6

G50.0

ICD-10 Finland

Trigeminal neuralgia

3.0

26.6

119

404

H53

ICD-10 Finland

Visual disturbances

4.4

26.6

155

H02AB04

ATC

methylprednisolone; systemic

1.6

26.5

769

5170

I63.5

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries

3.3

26.5

102

317

S80.0

ICD-10 Finland

Contusion of knee

1.8

26.4

421

2425

M48.0

ICD-10 Finland

Spinal stenosis

1.6

26.4

681

4458

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

26.3

893

6214

SFA10

NOMESCO Finland

One-surface restoration

1.3

26.2

3012

25776

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

26.2

2629

22054

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.0

26.2

275

1380

N06AX12

ATC

bupropion; oral

1.8

26.1

374

2084

ZXA00

NOMESCO Finland

Right side

1.4

26.1

1394

10577

Z02.7

ICD-10 Finland

Issue of medical certificate

1.8

26.0

428

2487

N05CF02

ATC

zolpidem; oral

1.5

26.0

903

6312

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.2

25.9

228

1070

S29

ICPC

Skin symptom/complaint other

1.4

25.9

1144

8386

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

3.6

25.8

244

K59.0

ICD-10 Finland

Constipation

1.9

25.8

328

1760

K90

ICPC

Stroke/cerebrovascular accident

2.4

25.7

179

760

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.1

25.7

246

1193

A03

ICPC

Fever

1.5

25.6

902

6321

XCH00

NOMESCO Finland

Eye pressure measurement

2.0

25.5

275

1393

L04AA31

ATC

[U] teriflunomide

7.8

25.5

J01FA10

ATC

azithromycin; systemic

1.3

25.5

3048

26189

N30.9

ICD-10 Finland

Cystitis, unspecified

1.8

25.5

377

2122

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.8

25.4

432

2534

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

25.4

1385

10539

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.8

25.3

362

2016

H25.1

ICD-10 Finland

Senile nuclear cataract

1.4

25.3

1455

11172

F95

ICPC

Strabismus

25.1

25.2

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.4

25.1

167

695

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.3

25.0

293

SPAT1254

SPAT

Administration of medicine

1.5

25.0

806

5544

G50.1

ICD-10 Finland

Atypical facial pain

3.0

24.9

113

387

P06

ICPC

Sleep disturbance

1.6

24.9

692

4604

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.6

24.9

626

4069

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.5

24.8

792

5433

C09AA05

ATC

ramipril; oral

1.4

24.8

1329

10076

S22.3

ICD-10 Finland

Fracture of rib

1.8

24.8

410

2387

N06AX26

ATC

vortioxetine; oral

1.8

24.7

410

2389

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.5

24.6

964

6895

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.7

24.5

497

3060

CA1AD

NOMESCO Finland

Orbita CT

8.7

24.5

B01AA03

ATC

warfarin; systemic

1.5

24.5

988

7108

R60.9

ICD-10 Finland

Oedema, unspecified

1.9

24.5

330

1804

M01AE02

ATC

naproxen; oral, rectal

1.3

24.3

3035

26161

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

5.9

24.3

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.6

24.3

144

568

ZXE20

NOMESCO Finland

More than three and less than five hours

1.5

24.2

711

4788

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

24.1

1916

15466

S00.0

ICD-10 Finland

Superficial injury of scalp

2.5

24.1

154

629

R4150

NOMESCO Finland

Neuropsychological rehabilitation

4.5

24.0

130

G04CA02

ATC

tamsulosin; oral

1.4

24.0

1246

9389

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

23.9

1607

12640

J01MA12

ATC

levofloxacin; systemic

1.5

23.9

985

7115

R03BA05

ATC

fluticasone; inhalant

1.5

23.9

942

6746

C10AX09

ATC

ezetimibe; oral

1.5

23.8

918

6543

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

5.1

23.8

K07.60

ICD-10 Finland

Snapping jaw

2.0

23.7

274

1422

L04AX01

ATC

azathioprine; systemic

2.1

23.7

235

1155

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.1

23.7

235

1155

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.7

23.7

509

3182

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

23.6

809

5629

SPAT1310

SPAT

Counselling related to known health issue

1.4

23.5

1675

13286

J01DA01

ATC

[U] cefalexin

1.3

23.5

3324

29097

N07CA01

ATC

betahistine; oral

1.8

23.5

395

2309

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.8

23.5

354

2004

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.9

23.4

113

401

N05CD07

ATC

temazepam; oral

1.6

23.4

591

3845

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.0

23.3

242

1209

ZX120

NOMESCO Finland

Intravenous

1.6

23.2

506

3174

A99

ICPC

Disease/condition unspecnature/site

1.6

23.0

579

3760

XF402

NOMESCO Finland

ECG with work load test

1.6

23.0

558

3593

M03BC01

ATC

orphenadrine (citrate); systemic

1.4

22.9

1131

8436

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.0

22.9

101

341

CS434

NOMESCO Finland

Visual field testing with Humphrey automated perimetry

2.4

22.8

152

634

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.7

22.7

121

452

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.9

22.7

313

1723

L15

ICPC

Knee symptom/complaint

1.4

22.7

1357

10456

SPAT1229

SPAT

Assessment of need for aid

1.7

22.7

411

2454

M79.7

ICD-10 Finland

Fibromyalgia

2.2

22.7

191

881

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.2

22.7

184

836

WZC30

NOMESCO Finland

Teaching

1.5

22.6

907

6511

M01AH01

ATC

celecoxib; oral

1.5

22.6

913

6563

T78.4

ICD-10 Finland

Allergy, unspecified

2.0

22.6

244

1238

C08DA01

ATC

verapamil; systemic

2.1

22.5

225

1109

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

22.5

2076

17091

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

3.7

22.4

190

M01AB05

ATC

diclofenac; systemic, rectal

1.3

22.3

3575

31722

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.5

22.3

684

4645

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

22.2

3647

32462

C01DA14

ATC

isosorbide mononitrate; oral

1.5

22.2

802

5638

SPAT1312

SPAT

General health counselling

1.3

22.1

1658

13231

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.1

22.1

206

989

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.6

22.1

557

3619

XKC03

NOMESCO Finland

Water cystometry

2.3

22.1

169

749

N07XX09

ATC

[U] dimethyl fumarate

9.0

22.1

A98

ICPC

Health maint/preventive medicine

1.8

22.0

5719

54932

C08CA01

ATC

amlodipine; oral

1.3

21.9

2094

17308

R21

ICPC

Throat symptom/complaint

1.4

21.8

1060

7876

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

2.8

21.8

107

383

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.2

21.8

183

843

TCW99

NOMESCO Finland

Other minor procedure in eye surgery

3.1

21.8

308

EBA00

NOMESCO Finland

Extraction of tooth

1.3

21.8

1955

16012

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

2.1

21.7

196

929

G44.0

ICD-10 Finland

Cluster headache syndrome

3.5

21.7

218

L04

ICPC

Chest symptom/complaint

1.8

21.7

357

2073

D12

ICPC

Constipation

2.1

21.7

220

1090

R31

ICD-10 Finland

Unspecified haematuria

1.6

21.6

558

3645

I69.0

ICD-10 Finland

Sequelae of subarachnoid haemorrhage

3.8

21.6

172

TCG00

NOMESCO Finland

Protection of cornea and sclera with soft lens

6.9

21.6

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

21.6

729

5053

H57.9

ICD-10 Finland

Disorder of eye and adnexa, unspecified

3.5

21.5

205

S21

ICPC

Skin texture symptom/complaint

1.5

21.5

838

5978

N29

ICPC

Neurological sympt/complt other

2.6

21.5

125

489

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

21.5

1356

10529

SPAT1216

SPAT

Assessment of functional ability

1.5

21.4

810

5744

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.9

21.3

271

1453

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

21.3

689

4733

S06.3

ICD-10 Finland

Focal brain injury

3.1

21.3

276

R25.1

ICD-10 Finland

Tremor, unspecified

2.2

21.3

187

878

R33

ICD-10 Finland

Retention of urine

1.7

21.2

438

2707

C09CA06

ATC

candesartan; oral

1.4

21.2

1270

9772

N05AA02

ATC

levomepromazine; systemic

2.1

21.2

210

1032

N06AA10

ATC

nortriptyline; systemic

2.6

21.2

120

463

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.7

21.2

402

2431

E0000UV, ,

ATC

1.3

21.1

2240

18754

SFA20

NOMESCO Finland

Two-surface restoration

1.3

21.1

3135

27443

R05

ICD-10 Finland

Cough

1.4

21.0

1154

8754

D32.0

ICD-10 Finland

Benign neoplasm: Cerebral meninges

6.3

21.0

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

20.9

689

4748

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

20.9

371

2201

R5140

NOMESCO Finland

Monitoring the use of the aid

1.6

20.9

587

3908

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.2

20.9

187

884

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.6

20.9

524

3400

W10

ICD-10 Finland

Fall on and from stairs and steps

1.8

20.8

299

1667

A08

ICPC

Swelling

1.8

20.8

326

1867

A29

ICPC

General symptom/complaint other

1.5

20.8

741

5191

Z00.0

ICD-10 Finland

General medical examination

1.4

20.8

1027

7650

L14

ICPC

Leg/thigh symptom/complaint

1.7

20.7

444

2771

SFA30

NOMESCO Finland

Three-surface restoration

1.3

20.7

2233

18723

SGA01

NOMESCO Finland

Emergency treatment

1.5

20.7

817

5838

R03BA02

ATC

budesonide; inhalant

1.4

20.7

915

6681

WX872

NOMESCO Finland

Intensive care

1.9

20.7

278

1519

P20

ICPC

Memory disturbance

1.5

20.7

760

5357

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.6

20.7

469

2970

H25.0

ICD-10 Finland

Senile incipient cataract

1.7

20.6

356

2097

SPAT1050

SPAT

Extensive neurological examination

2.5

20.6

130

529

N99

ICPC

Neurological disease other

3.0

20.6

292

D02

ICPC

Abdominal pain epigastric

1.8

20.5

341

1986

K10.3

ICD-10 Finland

Alveolitis of jaws

1.9

20.5

255

1358

R01AD08

ATC

fluticasone; nasal

1.3

20.5

1465

11584

K30

ICD-10 Finland

Functional dyspepsia

1.5

20.5

595

3992

H29

ICPC

Ear symptom/complaint other

1.5

20.4

660

4529

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.8

20.4

318

1818

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.6

20.4

514

3339

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.2

20.4

166

756

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.8

20.3

311

1768

J01FA06

ATC

roxithromycin; oral

1.3

20.3

2043

16958

C10AC01

ATC

colestyramine; oral

2.3

20.3

155

687

PA2BG

NOMESCO Finland

MRI examination of vessels in the head with high intensity magnet

4.5

20.3

110

G62.8

ICD-10 Finland

Other specified polyneuropathies

3.6

20.3

180

M31.5

ICD-10 Finland

Giant cell arteritis with polymyalgia rheumatica

3.5

20.3

199

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.5

20.2

657

4513

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.6

20.1

476

3044

ZXD35

NOMESCO Finland

Usual procedure

2.1

20.1

181

858

J02AC01

ATC

fluconazole; systemic

1.3

20.1

1960

16197

-1, ,

NOMESCO Finland

1.3

20.0

1697

13748

D09

ICPC

Nausea

1.9

19.9

251

1343

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.4

19.8

137

581

W17

ICD-10 Finland

Other fall from one level to another

2.0

19.8

227

1176

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.8

19.8

310

1775

XF600

NOMESCO Finland

Bloodpressure measurement

1.7

19.8

336

1970

AAC00

NOMESCO Finland

Ligature of intracranial aneurysm

3.4

19.8

212

L86

ICPC

Back syndrome with radiating pain

1.7

19.8

337

1978

WX140

NOMESCO Finland

Parabulbar anesthesy

1.9

19.7

253

1361

XQ800

NOMESCO Finland

Prick test

1.7

19.7

363

2176

K08.80

ICD-10 Finland

Toothache NOS

1.6

19.7

455

2892

TKC22

NOMESCO Finland

Catheterisation instruction

2.4

19.7

141

608

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.0

19.6

279

RS221, ,

NOMESCO Finland

3.0

19.6

295

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.5

19.6

563

3766

H49.9

ICD-10 Finland

Paralytic strabismus, unspecified

200.6

19.6

R52.1

ICD-10 Finland

Chronic intractable pain

3.6

19.5

180

H81.3

ICD-10 Finland

Other peripheral vertigo

2.2

19.5

163

750

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.5

19.5

705

4951

R39.1

ICD-10 Finland

Other difficulties with micturition

2.1

19.4

185

896

R03DC03

ATC

montelukast; oral

1.4

19.3

834

6057

KH1AD

NOMESCO Finland

CT of urinary organs

2.0

19.3

200

1000

P01

ICPC

Feeling anxious/nervous/tense

1.5

19.3

607

4141

J05AB01

ATC

aciclovir; systemic

1.4

19.3

1129

8642

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.5

19.1

124

511

PA2BC

NOMESCO Finland

Cerebral extensive angiography with X-ray

3.4

19.1

197

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

2.5

19.1

115

458

K08.3

ICD-10 Finland

Retained dental root

1.6

19.1

421

2647

N04BB01

ATC

amantadine; oral

2.8

19.0

333

8000/0-C70.0

ICD-O-3

Neoplasm, benign of cerebral meninges

6.0

19.0

N06BA07

ATC

modafinil; oral

5.7

19.0

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

18.9

964

7210

L29

ICPC

Musculoskeletal sympt/complt other

1.6

18.8

480

3125

R74

ICPC

Upper respiratory infection acute

1.3

18.8

1643

13346

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

2.1

18.8

179

868

M54.3

ICD-10 Finland

Sciatica

1.7

18.7

319

1871

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.1

18.7

255

N89

ICPC

Migraine

2.1

18.7

174

835

KMAK, ,

NOMESCO Finland

1.3

18.7

2636

22782

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.3

18.7

1387

11002

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

3.9

18.7

139

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.5

18.7

708

5014

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.7

18.7

375

2301

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.7

18.6

354

2140

ZXY02

NOMESCO Finland

Neuropsychologist

4.6

18.6

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.6

18.6

469

3044

R4130

NOMESCO Finland

Speech therapy

2.2

18.6

151

687

XCW20

NOMESCO Finland

Eye Movement Research, HESS

100.4

18.6

SPAT1153

SPAT

Removal of sutures

1.3

18.5

1628

13230

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

18.5

553

3731

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

2.0

18.5

192

961

R03BA08

ATC

ciclesonide; inhalant

1.6

18.5

438

2802

K04.1

ICD-10 Finland

Necrosis of pulp

1.5

18.5

561

3798

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.6

18.4

478

3123

PAW37

NOMESCO Finland

Biopsy of temporal artery

4.1

18.4

123

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

18.4

1409

11224

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.6

18.4

441

2828

G91.1

ICD-10 Finland

Obstructive hydrocephalus

5.5

18.3

M54.2

ICD-10 Finland

Cervicalgia

1.6

18.3

417

2641

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.5

18.3

650

4543

R03BB04

ATC

tiotropium bromide; inhalant

1.6

18.3

513

3411

C01CA24

ATC

epinephrine; parenteral

1.7

18.3

309

1808

K04.0

ICD-10 Finland

Pulpitis

1.6

18.3

445

2864

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

18.3

3351

29873

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.4

18.3

123

516

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.7

18.2

325

1932

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

18.2

1064

8134

N05BA09

ATC

clobazam; oral

4.6

18.2

F31

ICD-10 Finland

Bipolar affective disorder

3.1

18.2

239

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.4

18.1

882

6537

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

3.5

18.1

175

R27.0

ICD-10 Finland

Ataxia, unspecified

5.0

18.1

E23.00

ICD-10 Finland

Panhypopituitarism

5.7

18.0

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.4

18.0

996

7543

R03BA01

ATC

beclometasone; inhalant

1.5

18.0

700

4981

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

18.0

1157

8977

M01AH05

ATC

etoricoxib; oral

1.3

18.0

3320

29597

WX290

NOMESCO Finland

Other blockage of nerve

1.3

18.0

2453

21084

J45.1

ICD-10 Finland

Nonallergic asthma

1.7

17.9

365

2247

CAC30

NOMESCO Finland

Decompression of orbit to sinuses

52.7

17.9

M54.1

ICD-10 Finland

Radiculopathy

1.9

17.9

217

1147

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.5

17.9

527

3544

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.6

17.8

387

2422

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.1

17.8

164

785

TPH07

NOMESCO Finland

Cathetrisation of artery

1.5

17.8

590

4068

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

3.0

17.7

253

B01AC07

ATC

dipyridamole; systemic

2.0

17.7

205

1066

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

4.1

17.7

118

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.7

17.7

320

1909

H81.9

ICD-10 Finland

Disorder of vestibular function, unspecified

2.9

17.7

291

G44.8

ICD-10 Finland

Other specified headache syndromes

2.8

17.6

319

K89

ICPC

Transient cerebral ischaemia

3.2

17.6

218

H93.1

ICD-10 Finland

Tinnitus

1.7

17.6

364

2252

K04.08

ICD-10 Finland

Other specified pulpit

1.6

17.5

382

2395

N05AX08

ATC

risperidone; systemic

1.6

17.5

428

2759

S97

ICPC

Chronic ulcer skin

1.7

17.5

340

2069

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.6

17.5

400

2537

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

4.6

17.5

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.9

17.5

236

1292

3007

Kela drug reimbursment

Erenumab and fremanezumab

3.0

17.5

250

U01

ICPC

Dysuria/painful urination

1.6

17.5

410

2617

I95.1

ICD-10 Finland

Orthostatic hypotension

1.9

17.4

209

1101

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.6

17.4

461

3027

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

2.3

17.4

130

572

D35.2

ICD-10 Finland

Benign neoplasm: Pituitary gland

3.5

17.4

175

R03AK08

ATC

formoterol and beclometasone; inhalant

1.9

17.4

238

1309

S20.2

ICD-10 Finland

Contusion of thorax

1.8

17.3

282

1634

E89.00

ICD-10 Finland

Postirradiation hypothyroidism

3.2

17.3

210

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.7

17.3

335

2037

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

2.2

17.3

140

637

EB1VA, ,

NOMESCO Finland

1.4

17.2

915

6879

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.9

17.2

217

1162

P99

ICPC

Psychological disorders other

2.1

17.2

157

749

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.6

17.2

396

2516

M54.6

ICD-10 Finland

Pain in thoracic spine

1.6

17.2

370

2312

U05

ICPC

Urination problems other

1.7

17.2

292

1713

T74.1

ICD-10 Finland

Physical abuse

2.6

17.1

375

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.8

17.0

268

1537

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.6

17.0

400

2554

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.5

17.0

587

4079

XCW11

NOMESCO Finland

Assessment of strabismus

50.1

17.0

A07AA02

ATC

nystatin; oral

1.7

16.9

300

1780

G45.8

ICD-10 Finland

Other transient cerebral ischaemic attacks and related syndromes

3.8

16.9

131

C10AA07

ATC

rosuvastatin; oral

1.3

16.9

1753

14532

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.5

16.8

575

3986

L02

ICPC

Back symptom/complaint

1.5

16.8

521

3540

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.7

16.8

335

2052

B01AF02

ATC

apixaban; oral

1.4

16.8

710

5129

SGA03

NOMESCO Finland

Opening and preparing the root canals, complicated

1.5

16.8

473

3149

S05.1

ICD-10 Finland

Contusion of eyeball and orbital tissues

2.7

16.8

339

S09.9

ICD-10 Finland

Unspecified injury of head

2.5

16.7

101

403

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.6

16.7

443

2908

TKC20

NOMESCO Finland

Catheterisation of bladder

1.6

16.7

350

2171

Y04.9

ICD-10 Finland

Assault by bodily force by unknown person

3.7

16.7

137

S01.0

ICD-10 Finland

Open wound of scalp

1.6

16.7

424

2758

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.4

16.6

795

5871

N30

ICD-10 Finland

Cystitis

1.6

16.5

413

2675

E66.01

ICD-10 Finland

Obesity due to excess calories

1.6

16.5

456

3022

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.1

16.5

158

768

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.8

16.5

253

1441

M05BA04

ATC

alendronic acid; oral

1.6

16.5

432

2830

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

2.6

16.5

377

A97

ICPC

No disease

1.4

16.3

1056

8186

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.0

16.3

180

921

H51.9

ICD-10 Finland

Disorder of binocular movement, unspecified

40.2

16.3

D32.06

ICD-10 Finland

Benign tumor of the meninges os petrosum or clivus area

12.1

16.3

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.4

16.2

751

5513

A05

ICPC

Feeling ill

1.7

16.2

305

1840

P74

ICPC

Anxiety disorder/anxiety state

1.8

16.2

225

1243

J45

ICD-10 Finland

Asthma

1.5

16.2

523

3584

M01AG02

ATC

tolfenamic acid; oral, rectal

1.4

16.2

694

5024

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.6

16.2

361

2275

N06AX22

ATC

agomelatine; oral

2.3

16.2

123

545

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.8

16.2

242

1368

D07AC01

ATC

betamethasone; topical

1.3

16.2

1909

16062

A01AB09

ATC

miconazole; local oral

1.6

16.1

418

2730

K80

ICPC

Cardiac arrhythmia NOS

1.5

16.1

447

2966

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.8

16.1

251

1437

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

16.0

509

3477

G36.9

ICD-10 Finland

Acute disseminated demyelination, unspecified

11.7

16.0

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.5

16.0

466

3125

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.2

15.9

129

588

H81.4

ICD-10 Finland

Vertigo of central origin

3.4

15.8

171

GD1AD

NOMESCO Finland

Thorax CT examination

1.6

15.8

332

2061

G54.0

ICD-10 Finland

Brachial plexus disorders

2.2

15.8

129

589

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.7

15.8

323

1992

A02BA02

ATC

ranitidine; systemic

1.4

15.8

936

7157

CBJ40

NOMESCO Finland

Resection of levator muscle of eyelid

3.5

15.8

152

XX3DW

NOMESCO Finland

Time consuming IT work

1.5

15.7

551

3838

SPAT1255

SPAT

Intravenous administration of medicine

1.6

15.7

350

2205

C07AB02

ATC

metoprolol; systemic

1.4

15.7

982

7569

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.7

15.7

264

1544

N06AX03

ATC

mianserin; oral

1.8

15.7

235

1329

RS230, ,

NOMESCO Finland

4.3

15.7

G83.4

ICD-10 Finland

Cauda equina syndrome

4.9

15.6

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

15.6

1454

11857

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.5

15.6

476

3222

G46.3*I67.9

ICD-10 Finland

Brain stem stroke syndrome (I60-I67+)

4.8

15.6

WX704

NOMESCO Finland

Intubation

1.6

15.6

413

2710

J01DC02

ATC

cefuroxime; systemic

1.7

15.6

266

1562

R25.2

ICD-10 Finland

Cramp and spasm

2.2

15.6

131

606

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

15.5

1495

12244

N05AN01

ATC

lithium; oral

2.3

15.5

118

523

WZA90

NOMESCO Finland

Other medical or dental certificate

1.3

15.5

1173

9299

H52.0

ICD-10 Finland

Hypermetropia

2.3

15.5

111

480

H47.1

ICD-10 Finland

Papilloedema, unspecified

4.2

15.5

R32

ICD-10 Finland

Unspecified urinary incontinence

2.1

15.5

151

740

F61.0

ICD-10 Finland

Mixed personality disorders

2.7

15.4

313

N03AX18

ATC

lacosamide; systemic

3.6

15.4

140

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

3.4

15.4

164

IAB07

NOMESCO Finland

Consultation concerning a patient with self-harm intention

5.7

15.4

D32.9

ICD-10 Finland

Benign neoplasm: Meninges, unspecified

4.6

15.4

U04

ICPC

Incontinence urine

1.7

15.4

315

1944

L05

ICPC

Flank/axilla symptom/complaint

1.6

15.3

336

2110

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

15.3

913

6986

N05AE04

ATC

ziprasidone; systemic

4.2

15.3

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

3.2

15.3

180

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.8

15.2

228

1289

R90.8

ICD-10 Finland

Other abnormal findings on diagnostic imaging of central nervous system

2.9

15.2

243

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

15.2

661

4796

F01

ICPC

Eye pain

2.0

15.2

158

793

I67.9

ICD-10 Finland

Cerebrovascular disease, unspecified

3.2

15.2

191

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.6

15.1

340

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.3

15.1

1077

8463

L95

ICPC

Osteoporosis

1.9

15.1

204

1118

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

3.8

15.1

119

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

2.8

15.1

272

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

15.0

1326

10730

R41.0

ICD-10 Finland

Disorientation, unspecified

2.0

15.0

162

823

R07.0

ICD-10 Finland

Pain in throat

1.6

15.0

351

2238

R96

ICPC

Asthma

1.5

15.0

505

3489

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

3.2

15.0

182

N03AB02

ATC

phenytoin; systemic

3.0

15.0

213

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.5

15.0

432

2890

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.6

15.0

359

2303

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.5

15.0

519

3608

UDM02

NOMESCO Finland

Sinoscopy

2.2

14.9

118

532

N06AG02

ATC

moclobemide; oral

1.8

14.9

206

1137

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

14.9

2130

18287

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

2.2

14.9

119

539

SPAT1104

SPAT

Monitoring of emergency patient

1.6

14.9

324

2030

L13

ICPC

Hip symptom/complaint

1.3

14.9

994

7734

G40

ICD-10 Finland

Epilepsy

3.3

14.9

168

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

3.7

14.8

125

L16

ICPC

Ankle symptom/complaint

1.4

14.8

609

4372

J01CA08

ATC

pivmecillinam; oral

1.3

14.8

1989

16951

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.0

14.8

169

876

SPAT1325

SPAT

Vaccination

1.3

14.7

1710

14321

G72.9

ICD-10 Finland

Myopathy, unspecified

3.2

14.7

174

R06.5

ICD-10 Finland

Mouth breathing

1.5

14.7

446

3015

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.0

14.7

167

865

H02

ICPC

Hearing complaint

1.4

14.7

764

5717

WYA10

NOMESCO Finland

Emergency care or similar visit

1.6

14.6

348

2228

Z00.8

ICD-10 Finland

Other general examinations

1.5

14.6

403

2670

F34.1

ICD-10 Finland

Dysthymia

1.9

14.6

175

923

Q28.2

ICD-10 Finland

Arteriovenous malformation of cerebral vessels

6.3

14.5

G04CB01

ATC

finasteride; oral

1.5

14.5

533

3746

M02AA10

ATC

ketoprofen; topical

1.4

14.5

789

5944

S02.40

ICD-10 Finland

Fracture of malar and maxillary bones, closed

2.9

14.5

228

XKD03

NOMESCO Finland

Urethral pressure profilometry

2.2

14.5

115

520

SPAT1262

SPAT

Handing over of treatment supplies

1.4

14.4

876

6714

A10AC01

ATC

insulin (human); parenteral

1.6

14.4

361

2339

M01AX17

ATC

nimesulide; oral

1.3

14.4

1155

9219

R06.4

ICD-10 Finland

Hyperventilation

2.6

14.4

313

AN1

Coronary angiography

1.5

14.4

534

3761

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.5

14.4

408

2720

J01FA09

ATC

clarithromycin; systemic

1.3

14.4

1528

12655

AAE10

NOMESCO Finland

Transsphenoidal total or partial excision of intracranial lesion

5.2

14.4

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

2.3

14.3

102

440

R03AC03

ATC

terbutaline; inhalant

1.4

14.3

663

4864

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.0

14.3

156

797

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.8

14.2

202

1124

K07

ICPC

Swollen ankles/oedema

1.7

14.2

251

1488

R1260

NOMESCO Finland

Evaluation of communicative skills

2.5

14.2

344

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.3

14.2

925

7163

XCW10

NOMESCO Finland

Assessment of vision

2.4

14.2

386

H51.8

ICD-10 Finland

Other specified disorders of binocular movement

22.3

14.2

A10AB05

ATC

insulin aspart; parenteral

1.6

14.2

384

2534

K04

ICPC

Palpitations/awareness of heart

1.7

14.1

269

1631

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.6

14.0

297

1848

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

2.1

14.0

126

599

S16

ICPC

Bruise/contusion

1.9

14.0

162

845

UDC00

NOMESCO Finland

Ear microscopy

1.6

13.9

374

2462

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.7

13.9

238

1399

R5599

NOMESCO Finland

Other rehabilitation service

2.0

13.9

140

694

G45

ICD-10 Finland

Transient cerebral ischaemic attacks and related syndromes

3.8

13.9

112

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.5

13.9

435

2962

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.7

13.9

269

1637

A07AA09

ATC

vancomycin; oral

2.5

13.9

325

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

4.0

13.8

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.4

13.8

604

4384

G70.9

ICD-10 Finland

Myoneural disorder, unspecified

17.6

13.8

N88

ICPC

Epilepsy

3.6

13.8

122

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.2

13.8

116

537

S00.9

ICD-10 Finland

Superficial injury of head, part unspecified

2.7

13.8

285

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

13.8

2148

18576

F45.0

ICD-10 Finland

Somatization disorder

4.4

13.8

N05AE05

ATC

lurasidone; oral

4.9

13.8

G93.2

ICD-10 Finland

Benign intracranial hypertension

11.4

13.8

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.3

13.8

1100

8772

J20

ICD-10 Finland

Acute bronchitis

1.5

13.7

510

3591

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

3.8

13.7

109

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

4.2

13.6

F45.8

ICD-10 Finland

Other somatoform disorders

1.6

13.6

305

1924

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.6

13.6

309

1956

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.5

13.6

375

2483

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.3

13.6

1377

11321

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

1.8

13.6

191

1061

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.6

13.5

323

2070

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.6

13.5

289

1803

F45.9

ICD-10 Finland

Somatoform disorder, unspecified

5.4

13.5

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.3

13.5

1239

10059

A10AE04

ATC

insulin glargine; parenteral

1.5

13.5

476

3319

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.1

13.5

119

562

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

1.8

13.4

198

1115

104

Kela drug reimbursment

Thyroid insufficiency

1.6

13.4

343

2234

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

3.0

13.4

195

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

13.4

1188

9604

I63.8

ICD-10 Finland

Other cerebral infarction

3.0

13.4

190

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.2

13.3

104

467

PA2AC

NOMESCO Finland

Cerebral angiography with X-ray

4.4

13.3

L04AX03

ATC

methotrexate; systemic

1.5

13.3

473

3303

BAA60

NOMESCO Finland

Total thyroidectomy

2.1

13.3

125

605

M05BX04

ATC

denosumab; parenteral

1.6

13.2

316

2025

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.8

13.2

214

1239

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.7

13.2

237

1413

G40.10

ICD-10 Finland

Simple partial seizures

3.7

13.2

112

D10

ICPC

Vomiting

1.6

13.1

273

1691

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

1.8

13.1

208

1197

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.5

13.1

380

2544

ZXD20

NOMESCO Finland

Day surgery

1.4

13.1

604

4424

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.3

13.1

1249

10186

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

13.1

3590

32867

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.3

13.1

433

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

1.9

13.1

172

936

NG4AA

NOMESCO Finland

Lower leg X-ray examination

1.9

13.0

162

865

G63.2

ICD-10 Finland

Diabetic polyneuropathy

4.5

13.0

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.6

13.0

347

2281

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

13.0

1302

10682

R15

ICD-10 Finland

Faecal incontinence

2.0

13.0

146

754

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

2.4

13.0

360

J31.0

ICD-10 Finland

Chronic rhinitis

1.5

12.9

409

2789

IAB08

NOMESCO Finland

Consultation concerning a patient who has attempted suicide

5.2

12.9

N07AA03

ATC

distigmine; systemic

5.2

12.9

S06.2

ICD-10 Finland

Diffuse brain injury

2.9

12.9

199

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.8

12.9

194

1099

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

3.5

12.9

123

A23

ICPC

Risk factor NOS

1.5

12.9

462

3232

H52.3

ICD-10 Finland

Anisometropia and aniseikonia

3.1

12.8

163

R63.4

ICD-10 Finland

Abnormal weight loss

1.7

12.8

210

1220

S01EC01

ATC

acetazolamide; systemic

2.2

12.8

107

494

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

2.6

12.8

296

I20.09

ICD-10 Finland

Unstable angina

1.6

12.8

276

1726

H54.5

ICD-10 Finland

Severe visual impairment, monocular

4.7

12.8

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.4

12.8

543

3919

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

1.9

12.8

150

786

R01AD58

ATC

fluticasone, combinations; nasal

1.3

12.8

1197

9737

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.5

12.7

385

2601

WX725

NOMESCO Finland

Noninvasive ventilation

1.6

12.7

277

1736

PD5AD

NOMESCO Finland

CT of aorta

2.1

12.7

125

615

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.7

12.7

219

1291

R06.2

ICD-10 Finland

Wheezing

1.7

12.7

217

1276

G43.8

ICD-10 Finland

Other migraine

2.5

12.7

327

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.8

12.7

197

1128

N02CC03

ATC

zolmitriptan; nasal, oral

1.7

12.7

237

1429

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.6

12.7

328

2143

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.8

12.6

200

1151

SPAT1234

SPAT

Support of social functional capacity

1.7

12.6

253

1553

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.5

12.6

328

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.6

12.6

321

2089

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.3

12.6

1052

8428

H57.0

ICD-10 Finland

Anomalies of pupillary function

3.8

12.6

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.5

12.6

408

2797

CAC44

NOMESCO Finland

Combined decompression of orbit

70.0

12.6

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

3.0

12.6

181

N02CC04

ATC

rizatriptan; oral

1.7

12.6

245

1494

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

12.6

649

4845

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.7

12.5

219

1296

R30.0

ICD-10 Finland

Dysuria

1.7

12.5

215

1266

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

2.9

12.5

192

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.5

12.5

338

2230

NH1AD

NOMESCO Finland

Ankle and foot CT

2.1

12.5

123

606

K08.2

ICD-10 Finland

Atrophy of edentulous alveolar ridge

2.6

12.5

259

S00.8

ICD-10 Finland

Superficial injury of other parts of head

2.2

12.5

101

461

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.1

12.4

116

560

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

599

239

27.71

307.65

1.1

4.62

15.80

nmol/l

0.89

125

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3130

16609

2.84

307.65

2.9

2.2

186.12

221.10

u/l

0.33

3033

15675

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1807

8267

2.69

245.52

2.3

2.1

29.33

29.78

2.40

1755

8026

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

567

1281

4.78

233.86

1.4

1.3

592.17

543.24

mg/l

0.64

545

1222

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

291

344

8.84

227.97

1.2

1.1

58.67

43.42

mg/l

0.95

246

280

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

521

1126

4.97

226.49

1.3

3.65

3.77

mmol/l

1.60

493

1071

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

281

338

8.67

217.02

1.1

356.00

281.62

mg/l

0.85

252

286

(3013826) Glucose [Moles/volume] in Serum or Plasma

4424

31743

2.47

207.24

7.1

5.1

6.63

6.73

mmol/l

2.59

4303

30041

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

494

1109

4.76

204.73

1.4

39.87

30.68

e6/l

0.15

377

810

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

497

1127

4.72

203.43

1.5

1.4

1996.50

4459.78

e6/l

0.31

398

884

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

260

308

8.78

203.18

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

228

236

10.00

197.42

1.1

1.16

1.20

u/l

0.17

109

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

291

433

7.01

186.79

1.1

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

223

253

9.11

180.15

1.2

1.3

0.67

0.59

ratio

0.97

126

146

(3032080) INR in Blood by Coagulation assay

3650

25152

2.14

172.79

17.0

15.4

1.25

1.27

inr

1.12

3128

21036

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3854

27534

2.10

160.24

9.1

7.3

1.21

mmol/l

1.28

3439

23770

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3527

24615

2.04

153.35

8.2

6.6

1.21

mmol/l

0.97

3335

22791

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

885

3546

2.75

148.93

2.6

2.4

20.97

21.45

au/ml

0.05

365

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

814

3277

2.72

134.95

1.4

1.3

45.13

54.40

au/ml

0.52

227

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2974

20431

1.90

125.47

5.0

3.8

26.20

79.25

ng/l

1.72

2156

14440

(3024561) Albumin [Mass/volume] in Serum or Plasma

3399

24583

1.88

119.98

5.7

5.2

35.58

35.50

g/l

0.37

3226

23040

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

4810

39222

2.11

116.61

5.7

4.4

11.86

12.30

mm/h

1.36

4579

36678

(3001604) Monocytes [#/volume] in Blood

3677

27554

1.86

112.77

8.7

6.4

0.60

0.59

e9/l

0.47

3193

23576

(3006315) Basophils [#/volume] in Blood

3681

27625

1.85

112.00

8.7

6.4

0.04

e9/l

0.14

3193

23646

(3023410) Appearance of Cerebral spinal fluid

241

493

5.05

110.75

1.5

1.6

—

(3013115) Eosinophils [#/volume] in Blood

3754

28473

1.84

108.90

9.0

6.6

0.19

e9/l

0.04

3302

24798

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3752

28461

1.84

108.72

7.6

6.7

11.17

11.68

umol/l

1.48

3596

27169

(3019198) Lymphocytes [#/volume] in Blood

3716

28172

1.83

107.11

8.8

6.4

1.85

1.90

e9/l

0.80

3282

24731

(3005719) IgG [Mass/volume] in Serum or Plasma

895

4173

2.34

107.05

2.8

10.18

10.59

g/l

2.37

833

3841

(3018418) pH of Serum or Plasma

2466

16652

1.81

103.57

4.8

4.3

7.40

1.36

1861

11947

(3013650) Neutrophils [#/volume] in Blood by Automated count

3965

30861

1.83

102.55

12.2

9.7

4.15

e9/l

0.04

3492

26733

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4900

40873

2.05

102.06

10.5

8.4

79.47

79.21

u/l

0.14

4702

38848

(3033658) Prothrombin time (PT) actual/Normal

2127

13779

1.84

102.01

5.3

4.2

89.55

88.82

0.69

2092

13486

(3019069) Monocytes/Leukocytes in Blood

3409

25408

1.78

101.62

8.9

6.7

8.92

8.90

0.20

3256

23783

(3006504) Eosinophils/Leukocytes in Blood

3401

25338

1.78

101.45

8.8

6.6

2.84

0.03

3245

23709

(3031040) Bacteria [#/volume] in Urine by Automated count

4381

35246

1.89

100.91

6.9

4.7

751.89

1879.92

e6/l

1.88

491

(3022096) Basophils/Leukocytes in Blood

3391

25327

1.77

99.42

8.9

6.7

0.68

0.23

3238

23681

(3002030) Lymphocytes/Leukocytes in Blood

3454

25979

1.77

98.39

8.8

6.6

26.88

27.49

2.75

3318

24576

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

12.15

96.90

1.1

—

(3018010) Neutrophils/Leukocytes in Blood

3392

25486

1.75

95.92

8.7

6.5

58.01

57.54

1.55

3285

24318

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1709

10540

1.87

94.51

5.1

3.9

260.04

471.49

ng/l

1.26

1313

8323

(3037467) Urinalysis macro (dipstick) panel - Urine

4464

36588

1.84

91.06

6.4

4.6

3.00

2.54

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

558

2255

2.62

90.23

1.8

1.9

38.01

39.49

u/l

0.97

508

2004

(3023368) Bacteria identified in Blood by Culture

2252

15396

1.74

86.30

5.3

4.4

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3208

24288

1.68

83.08

2.4

2.1

95.77

95.55

pmol/l

0.09

1759

12948

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1521

9358

1.84

82.98

2.2

1.9

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

188

398

4.84

82.89

1.3

1.97

2.19

mmol/l

1.32

171

373

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4781

40550

1.86

80.76

5.7

4.4

14.81

14.80

pmol/l

0.08

4451

37245

(3026008) Bacteria identified in Urine by Culture

2380

16752

1.69

80.44

4.1

3.3

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2333

16447

1.68

77.62

3.6

3.2

1213.64

1438.96

ng/l

1.52

2020

14221

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1493

9324

1.80

76.58

3.8

3.4

0.82

0.81

mmol/l

0.44

1416

8777

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1193

6975

1.89

75.62

2.1

1.8

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

5657

51365

2.60

74.06

25.3

16.5

22.70

24.73

mg/l

5.39

4957

42555

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1789

11861

1.72

74.01

2.2

1.7

1.17

1.29

mg/l

0.77

1392

9242

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

391

1461

2.79

73.37

2.7

2.0

4.16

7.80

iu/l

0.46

176

601

(3036481) Cortisol [Moles/volume] in Serum or Plasma

936

5118

1.98

72.19

2.5

2.3

363.81

381.94

nmol/l

1.99

877

4740

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2401

17300

1.64

71.79

3.5

2.7

53.82

65.21

u/l

1.81

2236

16067

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

5376

47939

2.11

71.13

7.1

5.4

1.86

1.92

mu/l

3.20

5078

44424

(3002582) Erythrocytes [#/volume] in Urine

2492

18159

1.63

70.99

4.7

3.5

93.58

78.42

e6/l

0.20

1975

13885

(3021960) Folate [Moles/volume] in Serum or Plasma

2228

15804

1.65

70.55

1.8

1.7

19.55

20.11

nmol/l

1.05

1937

13430

(3015736) pH of Urine

3003

22946

1.61

70.16

4.5

3.5

6.30

6.24

2.35

1638

12793

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

199

509

4.01

68.84

1.6

1.5

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

2550

18857

1.61

67.28

3.5

3.6

2.34

2.35

mmol/l

4.28

2299

17154

(3018095) Leukocytes [#/volume] in Urine

2734

20600

1.60

66.40

5.6

4.0

89.37

97.28

e6/l

0.14

2034

14555

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1108

6585

1.84

65.68

8.4

7.7

5.14

5.10

kpa

0.66

1062

6340

(3019550) Sodium [Moles/volume] in Serum or Plasma

5701

52348

2.59

65.63

29.1

19.4

139.69

139.65

mmol/l

0.52

5658

51350

(3027801) Oxygen [Partial pressure] in Arterial blood

1107

6583

1.83

65.47

8.4

7.7

12.32

12.31

kpa

0.02

1065

6337

(3019977) pH of Arterial blood

1105

6576

1.83

65.16

8.5

7.8

7.42

0.26

645

3636

(3035350) Ketones [Presence] in Urine by Test strip

3583

28866

1.59

64.68

5.2

3.9

12.19

4.01

estimate

0.95

747

6197

(3003396) Base excess in Arterial blood by calculation

1099

6543

1.83

64.67

8.5

7.7

1.07

0.97

mmol/l

0.36

917

5355

(3021601) Nitrite [Presence] in Urine by Test strip

3549

28538

1.59

64.50

5.2

3.9

0.00

estimate

1.08

725

6051

(3030467) Casts [#/volume] in Urine by Automated count

2187

15709

1.61

64.26

4.4

3.3

0.37

0.42

e6/l

0.53

1675

11561

(3023103) Potassium [Moles/volume] in Serum or Plasma

5703

52448

2.57

64.09

29.4

19.5

3.96

3.97

mmol/l

1.90

5650

51355

(3009261) Glucose [Presence] in Urine by Test strip

3596

29045

1.59

63.77

5.2

4.0

0.03

0.06

estimate

0.32

699

5818

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

11.10

63.23

3.3

2.5

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1095

6560

1.82

62.96

2.2

1.9

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

109

183

6.05

62.03

1.2

1.1

1651.28

216.50

ng/l

1.09

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2049

14698

1.60

59.36

2.7

2.4

2.82

mg/l

0.02

1816

12740

(3037522) Nuclear Ab [Titer] in Serum

1207

7562

1.75

59.15

1.5

1.4

418.96

532.46

titre

1.71

268

1650

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3105

24533

1.55

58.36

2.9

2.4

76.39

77.63

nmol/l

1.67

2875

22218

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1467

9774

1.66

56.92

3.9

3.0

1.07

1.09

e6/l

0.07

807

5210

(3016502) Oxygen saturation in Arterial blood

985

5877

1.81

56.85

8.8

8.0

95.71

95.56

0.34

957

5676

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

11.70

56.71

1.2

1.1

—

(3000850) Epithelial cells [#/volume] in Urine

1796

12606

1.60

56.37

3.5

2.8

5.46

5.54

e6/l

0.10

1649

11513

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

4156

35185

1.58

56.22

4.4

3.3

51.42

48.38

u/l

1.06

3969

33001

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3158

25277

1.52

54.25

3.3

2.8

—

estimate

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3189

25597

1.52

53.92

3.6

3.1

127.86

126.93

ug/l

0.06

2973

23921

(3044640) Blood type and Crossmatch panel - Blood

2359

17758

1.54

53.85

3.0

2.5

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1164

7396

1.71

53.60

6.3

6.1

1.03

1.04

mmol/l

0.91

1094

6901

(3002173) Hemoglobin [Mass/volume] in Arterial blood

917

5463

1.80

52.87

9.5

8.5

121.65

121.13

g/l

0.33

897

5339

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2393

18127

1.53

52.75

4.0

3.3

35.24

35.19

u/l

0.00

2287

17090

(3007164) IgA [Mass/volume] in Serum or Plasma

1562

10766

1.61

52.13

1.7

1.5

2.37

2.45

g/l

0.78

974

6666

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

117

247

4.81

51.78

1.5

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1343

8962

1.64

50.95

4.1

3.2

3.80

2.46

e6/l

2.93

669

4390

(3019309) Folate [Moles/volume] in Red Blood Cells

1376

9255

1.63

50.51

1.8

1100.22

1168.79

nmol/l

2.08

1094

7045

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

7.69

50.05

1.2

1.3

—

(3026782) Osmolality of Urine

1550

10750

1.59

50.05

3.5

3.0

536.41

531.59

mosm/kgh2o

0.37

1387

9471

(3028026) IgM [Mass/volume] in Serum or Plasma

617

3303

1.97

49.48

2.2

1.9

1.19

1.34

g/l

0.91

579

3037

(3022948) Iron [Moles/volume] in Serum or Plasma

1416

9653

1.61

48.97

2.7

2.6

12.79

12.89

umol/l

0.19

1322

9014

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

119

275

4.39

47.12

1.1

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1833

13495

1.51

44.20

2.9

2.4

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1697

12295

1.53

44.12

1.4

1.3

1.86

1.90

u/ml

0.03

448

3326

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

601

3340

1.89

42.83

4.0

3.4

4.45

4.49

pmol/l

0.30

549

2986

(3036489) Thrombin time

409

1991

2.13

42.38

2.4

2.1

21.02

21.18

0.13

365

1759

(3007853) Bacteria identified in Skin by Aerobe culture

993

6405

1.66

42.15

2.0

1.8

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

828

5095

1.72

41.93

9.5

7.6

1.31

1.33

mmol/l

0.18

810

4999

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1306

9031

1.57

41.51

2.7

2.6

2.34

2.31

g/l

1.14

1211

8354

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

365

1716

2.20

41.30

1.7

1.20

1.19

g/l

0.22

356

1629

(3021589) Normoblasts [#/volume] in Blood

2939

23955

1.44

41.23

14.6

11.8

0.00

e9/l

1.97

2408

19518

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1219

8308

1.59

41.22

2.7

22.09

22.50

0.47

1131

7734

(3011397) Hemoglobin [Presence] in Urine by Test strip

1790

13267

1.50

41.17

5.0

3.8

0.27

0.45

0.17

143

(3021447) Carbon dioxide [Partial pressure] in Venous blood

904

5724

1.68

41.12

5.1

3.8

5.82

kpa

0.08

877

5577

(3020630) Protein [Mass/volume] in Serum or Plasma

785

4792

1.73

40.84

2.6

66.07

66.18

g/l

0.16

725

4394

(3002032) Base excess in Venous blood by calculation

881

5564

1.68

40.41

5.1

3.8

1.85

1.84

mmol/l

0.03

786

4862

(3014148) Varicella zoster virus Ab [Titer] in Serum

190

665

2.92

40.12

1.2

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

5350

49345

1.74

39.93

23.2

16.1

80.98

80.49

ml/min/173m2

0.94

5069

45690

(40758558) Short blood count panel - Blood

2127

16400

1.46

39.69

7.6

6.5

—

(3012544) pH of Venous blood

907

5802

1.66

39.54

5.1

3.8

7.38

0.84

528

3353

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

352

1662

2.19

39.38

1.7

0.23

0.24

g/l

0.77

341

1577

(3000991) Gas panel - Venous blood

790

4879

1.71

39.30

11.0

8.9

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

162

5.12

39.25

1.0

1.1

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

5759

54491

2.23

38.30

31.6

21.4

78.70

78.22

umol/l

0.48

5726

53851

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

743

4543

1.72

38.27

3.0

2.3

7.03

7.45

ug/l

0.19

657

3992

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

102

246

4.20

38.26

1.1

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

679

4058

1.76

37.91

1.8

1.7

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

310

1420

2.25

37.35

1.8

2.0

12.81

11.78

mg/l

0.31

293

1321

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

5257

48438

1.66

37.13

7.6

6.4

39.93

39.31

mmol/mol

5.03

4947

45389

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

586

3378

1.81

36.94

10.5

9.6

24.48

24.27

mmol/l

0.79

572

3316

(3044889) 12 lead EKG panel

4173

36689

1.44

36.21

5.0

4.1

0.40

5351.45

—

(3024354) Oxygen [Partial pressure] in Venous blood

762

4772

1.68

35.79

4.7

3.2

4.53

4.55

kpa

0.06

737

4636

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

242

4.10

35.65

1.2

1.3

55.86

66.55

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

584

3402

1.79

35.49

2.0

1.7

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

979

6540

1.59

35.48

4.2

4.5

238.08

243.12

u/l

0.51

928

6204

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

385

1961

2.03

35.24

2.7

2.2

253.31

660.17

ug/l

2.99

364

1863

(3042936) Bacteria identified in Isolate by Culture

1139

7899

1.54

34.98

2.4

2.0

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

349

1725

2.09

34.65

1.7

1.5

37.51

6.93

iu/ml

0.46

318

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

5329

49450

1.66

34.43

5.9

5.2

6.00

5.95

mmol/l

2.01

4982

45511

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5711

54091

2.03

34.25

17.0

12.2

26.10

26.07

u/l

0.05

5598

52546

(3009508) Creatinine [Moles/volume] in Urine

2377

19069

1.41

34.16

3.9

3.5

7.58

7.52

mmol/l

0.22

2015

16145

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1540

11417

1.47

34.13

1.8

1.7

23448717.72

32006300.78

pmol/l

0.25

1305

9542

(3014051) Protein [Presence] in Urine by Test strip

1970

15316

1.42

33.74

3.7

2.9

0.00

0.06

3.14

373

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

557

3260

1.78

33.24

10.5

10.0

16.00

15.99

0.01

540

3146

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1357

9867

1.48

33.01

1.4

1.3

25.44

31.26

iu/ml

0.98

373

2974

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1475

10917

1.46

32.74

3.0

3.1

2.44

2.45

mmol/l

2.49

1307

9765

(3009445) Proteinase 3 Ab [Units/volume] in Serum

431

2350

1.90

32.31

1.7

1.6

11.14

16.63

iu/ml

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

675

4213

1.68

31.91

3.8

3.9

87.41

91.85

ng/l

0.49

597

3606

(3009466) Valproate [Moles/volume] in Serum or Plasma

183

709

2.63

31.88

5.4

367.37

357.83

umol/l

0.34

159

626

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3664

31802

1.39

31.85

3.5

3.0

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

581

3483

1.74

31.85

7.2

6.8

24.69

24.51

mmol/l

0.62

556

3336

(3017143) Hepatitis C virus Ab [Presence] in Serum

902

6074

1.57

31.24

1.7

1.6

—

(3027945) Reticulocytes/Erythrocytes in Blood

951

6518

1.54

30.38

2.6

1.78

0.04

837

5810

(3020779) Urea [Moles/volume] in Serum or Plasma

785

5153

1.60

30.26

7.5

7.4

9.10

10.11

mmol/l

3.63

749

4950

(46235355) HIV 1 and 2 tests - Meaningful Use set

1299

9508

1.47

30.17

2.0

1.9

—

(36660697) Celiac disease serology panel - Serum

674

4280

1.65

29.70

1.2

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

929

6381

1.54

29.30

3.0

2.9

8.86

8.57

umol/l

0.12

809

5600

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2599

21555

1.36

28.87

5.2

3.9

0.05

0.27

estimate

0.82

611

4963

(3015171) Extractable nuclear Ab [Units/volume] in Serum

388

2120

1.89

28.85

1.3

0.39

1.24

u/ml

1.94

182

(3011412) CD3 cells [#/volume] in Blood

138

488

2.87

28.67

2.6

2.4

1258.37

1138.94

e6/l

0.99

120

429

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

194

814

2.43

28.62

1.3

5.63

3.25

u/ml

0.80

285

(3013512) EKG study

2277

18549

1.37

28.14

4.6

3.7

0.80

0.73

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

106

325

3.30

28.14

2.9

2.8

202.68

217.41

e6/l

0.38

277

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

369

2002

1.90

28.03

1.3

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

787

5271

1.57

27.67

3.1

2.5

36.36

49.37

u/l

0.72

664

4449

(3019150) Specific gravity of Urine by Refractometry

1642

12710

1.40

27.63

5.6

4.1

1.02

1.25

kg/l

0.80

1162

8493

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

320

1665

1.97

27.52

2.6

2.3

96.38

92.38

2.52

306

1605

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

301

1538

2.01

27.26

3.1

2.5

182.75

195.33

1.63

286

1461

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

134

4.66

26.79

1.0

1.1

—

(3029937) Albumin [Presence] in Urine by Test strip

1985

15947

1.36

26.33

5.5

4.1

0.00

estimate

0.05

683

5561

(3000060) B lymphocytes [#/volume] in Blood

132

4.66

26.33

2.4

2.2

1.79

0.34

e9/l

0.39

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

5145

47943

1.49

26.10

4.8

4.3

1.30

1.29

mmol/l

0.71

4784

44139

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

437

2557

1.76

25.94

5.4

5.1

1.66

1.62

0.25

415

2421

(3048689) Calprotectin [Mass/mass] in Stool

967

6862

1.49

25.82

2.4

169.92

136.25

ug/g

0.65

768

5487

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

540

3353

1.67

25.82

5.0

3.9

24.42

24.22

mmol/l

0.90

532

3317

(3000494) Fungus identified in Specimen by Culture

930

6562

1.49

25.52

1.6

1.5

—

(3005322) IgE [Units/volume] in Serum or Plasma

541

3376

1.66

25.37

1.4

1.3

272.62

256.41

u/ml

0.09

506

3129

(3004119) Hemoglobin [Mass/volume] in Venous blood

558

3512

1.65

25.30

4.8

3.1

129.87

129.15

g/l

0.33

539

3408

(3021879) Hepatitis B virus core Ab [Presence] in Serum

629

4084

1.60

25.14

1.5

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

294

1537

1.96

24.94

1.5

23.01

13.16

iu/ml

—

(3012516) Albumin [Mass/volume] in Urine

2178

17860

1.34

24.90

3.7

3.5

52.95

48.70

mg/l

0.25

1413

11509

(3006653) Thiamine [Moles/volume] in Blood

265

3.39

24.79

1.4

1.3

127.19

133.61

nmol/l

0.69

265

(40768797) Stomach Pathology biopsy report

1032

7496

1.45

24.32

1.3

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

100

324

3.12

24.29

2.9

2.6

470.81

527.66

e6/l

0.57

259

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1102

8108

1.44

24.24

1.7

—

(3028707) Methadone [Presence] in Urine by Screen method

187

832

2.29

24.19

4.5

3.0

—

(3020682) Albumin/Creatinine [Ratio] in Urine

2207

18190

1.34

24.18

4.4

4.2

8.27

8.94

mg/mmol

0.31

1395

11457

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

5796

55780

1.97

23.94

38.6

25.4

40.03

40.71

3.12

5771

55166

(3007461) Platelets [#/volume] in Blood

5795

55768

1.97

23.92

37.9

24.9

250.02

250.11

e9/l

0.04

5734

54668

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1219

9153

1.42

23.91

1.3

10.41

12.06

u/ml

0.31

443

3560

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

181

799

2.30

23.85

1.4

1.3

4.00

4.10

u/ml

0.04

356

(3035941) MCH [Entitic mass]

5795

55773

1.97

23.84

37.7

24.8

30.29

30.34

1.50

5771

55188

(3010813) Leukocytes [#/volume] in Blood

5796

55786

1.97

23.84

37.8

24.9

6.93

6.76

e9/l

3.19

5713

54504

(3024731) MCV [Entitic mean volume] in Red Blood Cells

5795

55775

1.97

23.81

37.7

24.8

91.13

91.16

0.21

5772

55187

(3026361) Erythrocytes [#/volume] in Blood

5795

55780

1.96

23.72

37.8

24.9

4.45

4.48

e12/l

3.13

5716

54500

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

469

2871

1.69

23.62

1.6

1.5

—

(3000963) Hemoglobin [Mass/volume] in Blood

5795

55792

1.96

23.52

38.1

25.1

133.73

134.85

g/l

7.25

5769

55218

(3006245) CD3-CD19+ cells/cells in Blood

189

3.79

23.39

2.9

2.2

9.13

10.27

0.22

176

(40768804) Tissue Pathology biopsy report

2547

21514

1.32

23.19

2.3

2.2

—

(4268621) Lupus anticoagulant assay

140

563

2.52

22.69

2.5

2.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

5421

51343

1.55

22.63

6.7

5.8

2.58

2.69

mmol/l

16.54

5117

47866

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

430

2601

1.70

22.63

1.1

6.03

1.18

u/ml

—

(3017732) Neutrophils [#/volume] in Blood

952

6928

1.44

22.01

3.6

3.3

4.89

4.61

e9/l

0.39

812

5986

(3045414) Leukocytes [Presence] in Urine

765

5343

1.49

21.83

2.4

2.1

0.03

0.01

estimate

0.40

132

1123

(3023420) DNA double strand Ab [Units/volume] in Serum

379

2239

1.74

21.72

1.9

1.8

6.23

6.75

iu/ml

0.16

540

(3023520) Reticulocytes [#/volume] in Blood

729

5051

1.50

21.62

2.4

2.7

68.68

69.30

e9/l

0.18

549

3685

(3007930) Methemoglobin/Hemoglobin.total in Blood

393

2354

1.72

21.43

5.6

5.3

0.88

0.87

0.07

373

2227

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

166

743

2.27

21.21

1.2

121.05

115.41

1.33

153

670

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

306

1710

1.83

21.17

1.3

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

5342

50554

1.49

21.13

5.9

5.1

4.46

4.61

mmol/l

22.42

5053

47306

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

319

2.98

21.13

1.9

1.7

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

5315

50249

1.48

21.12

5.8

5.0

1.42

1.46

mmol/l

9.35

4995

46730

(3021387) Prolactin [Units/volume] in Serum or Plasma

308

1727

1.83

21.07

1.9

1.6

394.56

295.98

mu/l

0.50

280

1585

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

772

5443

1.48

20.97

2.4

2.3

0.22

0.21

g/l

2.28

710

5095

(3047181) Lactate [Moles/volume] in Blood

301

1683

1.83

20.78

5.7

6.1

1.22

1.32

mmol/l

1.02

274

1490

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

644

4399

1.52

20.38

3.6

3.0

174.27

201.24

ng/l

0.96

580

4015

(4195642) Thrombophilia screening test

163

737

2.25

20.34

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

5.09

20.20

1.2

1.1

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

464

2949

1.62

20.13

4.7

2.8

1.27

1.22

0.41

459

2930

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

4631

42870

1.34

20.00

30.3

20.2

13.74

13.65

5.00

4601

42315

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

136

576

2.39

19.75

1.2

100.94

96.03

1.21

128

537

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

310

1786

1.78

19.38

2.6

2.2

1769.28

5682.08

u/l

3.93

697

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

852

6209

1.43

19.36

2.0

1.8

1.56

1.48

2.77

742

5459

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

140

608

2.33

19.23

1.7

1.8

1213.33

1129.60

titre

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

322

1894

1.74

18.74

3.1

2.7

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

208

1072

1.97

18.44

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

208

1072

1.97

18.44

1.4

1.3

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

102

390

2.64

18.40

2.4

2.0

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

4.74

18.19

2.1

2.0

22.45

15.68

umol/l

2.02

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

536

3605

1.53

18.17

1.3

1.2

121.01

141.89

u/ml

0.66

193

1332

(3024980) IgG subclass 4 [Mass/volume] in Serum

187

936

2.03

18.01

1.8

1.6

0.82

0.78

g/l

0.18

141

726

(44816559) Phosphatidylethanol [Mass/volume] in Blood

366

2253

1.66

18.00

2.0

1.6

0.32

0.30

mg/l

0.18

173

1047

(40760892) CBC W Ordered Manual Differential panel - Blood

1505

12149

1.32

17.83

6.6

4.8

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1742

14347

1.30

17.81

3.2

2.8

336.31

344.75

umol/l

2.83

1538

12668

(3023183) Ammonium ion [Moles/volume] in Plasma

227

1221

1.89

17.74

2.6

2.9

31.20

34.26

umol/l

1.21

203

1104

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2539

21950

1.27

17.61

2.1

1.9

1.37

1.36

mmol/l

0.28

2155

18453

(3002179) Metamyelocytes/Leukocytes in Blood

676

4804

1.46

17.47

5.0

4.4

0.55

0.72

1.89

227

1439

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

133

3.86

17.37

1.0

1.1

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

652

4607

1.47

17.36

3.6

2.5

0.26

0.47

e6/l

3.05

635

4414

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

161

3.56

17.31

1.2

24.83

19.90

—

(3025941) Bacteria identified in Stool by Culture

433

2808

1.58

17.24

1.3

1.2

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

376

2357

1.63

17.22

2.1

2.3

3.52

3.72

g/l

2.50

346

2167

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

376

2358

1.63

17.19

2.1

2.3

4.20

g/l

0.02

345

2167

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

376

2359

1.63

17.16

2.1

2.3

7.32

7.42

g/l

0.59

346

2167

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

282

1639

1.76

17.12

1.3

60.36

37.71

u/ml

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

356

2205

1.65

17.10

2.0

2.3

2.82

2.93

g/l

1.11

326

2015

(3022145) Colonoscopy Study observation

836

6203

1.40

17.01

1.4

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

5.91

16.95

1.8

2.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1838

15325

1.29

16.90

4.2

3.4

0.42

0.25

estimate

0.16

604

4762

(3023511) Choriogonadotropin [Units/volume] in Urine

170

843

2.05

16.82

1.6

1.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

292

1724

1.73

16.78

1.4

1.3

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

268

2.90

16.63

1.1

1566.18

1474.54

miu/ml

0.28

268

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

161

788

2.07

16.51

1.1

—

(3017181) Myelocytes/Leukocytes in Blood

698

5056

1.43

16.23

5.1

4.5

0.95

0.93

0.05

234

1529

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

320

1955

1.67

16.21

3.2

3.4

47.38

53.97

mg/l

0.19

277

1657

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

12.78

16.11

1.1

1.2

—

(3024928) Oxygen saturation in Venous blood

251

1436

1.78

16.10

5.4

2.9

61.82

61.33

0.13

238

1394

(3027273) Bicarbonate [Moles/volume] in Venous blood

390

2508

1.59

16.09

4.8

3.4

25.22

25.27

mmol/l

0.10

375

2421

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

252

2.92

16.01

3.9

2.0

134.59

129.36

umol/l

0.06

135

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

231

1293

1.82

15.94

1.3

1.2

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

278

1645

1.72

15.86

3.7

2.6

3.58

3.57

g/l

0.05

268

1566

(1001926) Buprenorphine [Presence] in Urine by Screen method

262

1526

1.75

15.81

4.0

2.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

422

2776

1.56

15.78

2.4

—

(21494815) CD4 cells/Lymphocytes in Specimen

104

435

2.42

15.62

2.1

2.3

41.87

39.24

0.93

104

424

(3020191) Ethanol [Moles/volume] in Serum or Plasma

105

442

2.40

15.55

1.9

1.5

1.12

1.18

promille

0.13

349

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

130

3.71

15.53

1.0

—

(3025159) Blasts/Leukocytes in Blood

672

4877

1.43

15.43

5.5

4.7

0.12

0.26

0.80

193

1239

(3011288) Drugs identified in Urine by Screen method Nominal

237

1351

1.79

15.40

6.2

3.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

317

1958

1.65

15.40

3.2

3.4

48.52

83.62

mg/l

0.67

276

1660

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

325

2026

1.64

15.23

2.1

2.3

9.60

10.24

g/l

2.15

292

1815

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.02

15.23

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

137

3.60

15.15

1.1

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

268

2.78

14.90

14.9

13.8

0.60

0.62

mmol/l

0.36

250

(3039000) Anion gap in Blood by calculation

208

1152

1.83

14.88

6.6

7.2

10.79

11.34

mmol/l

1.65

190

1033

(3018572) Chloride [Moles/volume] in Blood

208

1153

1.83

14.84

6.6

7.2

105.61

105.03

mmol/l

1.00

190

1034

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

314

1954

1.64

14.82

2.1

1.8

—

(3019225) pH of Specimen

700

5163

1.40

14.63

5.0

4.3

7.38

7.35

5.88

525

3692

(3000570) Elastase.pancreatic [Mass/mass] in Stool

274

1659

1.68

14.38

1.5

1.4

273.38

272.23

ug/g

0.03

159

959

(3027135) IgG subclass 1 [Mass/volume] in Serum

123

574

2.17

14.32

1.8

1.3

5.91

6.91

g/l

3.40

414

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

123

575

2.16

14.26

1.5

1.7

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

359

2330

1.57

14.24

2.1

1.9

1.55

2.29

ug/l

0.53

313

2068

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

124

3.65

14.23

1.1

—

(3018405) Lactate [Moles/volume] in Arterial blood

291

1798

1.65

14.14

4.3

3.9

1.31

1.40

mmol/l

0.83

284

1768

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1151

9213

1.31

14.03

1.7

1.5

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

122

573

2.15

13.99

1.8

1.3

0.39

0.41

g/l

0.31

415

(3028192) IgG subclass 2 [Mass/volume] in Serum

122

573

2.15

13.99

1.8

1.3

2.89

2.93

g/l

0.08

415

(3021440) Promyelocytes/Leukocytes in Blood

659

4847

1.40

13.98

5.3

4.6

0.10

0.12

0.30

192

1324

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

232

1354

1.74

13.93

1.2

1.1

4.04

4.28

0.13

174

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

165

3.23

13.91

3.5

2.7

30.74

28.92

umol/l

0.24

119

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

4.59

13.74

1.1

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

416

2818

1.51

13.59

5.4

3.9

48.51

47.37

0.43

410

2770

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

565

4065

1.43

13.56

1.5

1.4

—

(3016879) Cocaine [Presence] in Urine

288

1795

1.63

13.53

3.9

2.3

—

(3010838) Calcium [Moles/time] in 24 hour Urine

171

922

1.88

13.35

1.7

1.9

4.73

4.84

mmol/24h

0.17

158

814

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

246

1478

1.69

13.31

1.6

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

281

1749

1.64

13.27

3.1

3.2

2.17

3.59

ratio

0.99

169

994

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

204

1165

1.78

13.23

5.1

5.8

1267.43

1811.38

iu/ml

0.13

163

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

208

1196

1.77

13.17

1.2

50.76

41.21

u/ml

0.29

125

(3045424) Erythrocytes [Presence] in Urine

402

2724

1.51

13.12

2.3

2.2

0.03

0.30

estimate

0.47

100

880

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

260

1592

1.66

13.10

1.7

—

(3052851) Hemolysis interference index of Serum or Plasma

248

1501

1.68

13.06

3.4

3.3

1.88

1.92

index

0.04

144

773

(3042517) Benzodiazepines panel - Urine

5.45

13.04

3.0

2.9

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

112

531

2.13

12.58

1.5

1.8

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

168

919

1.85

12.56

2.3

2.9

639.56

1342.02

u/ml

—

(3000764) Benzodiazepines [Presence] in Urine

301

1936

1.58

12.44

3.9

2.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

250

1540

1.65

12.32

1.3

7.08

6.94

u/ml

0.02

237

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

449

3151

1.46

12.31

3.5

3.6

1.66

1.92

mmol/l

0.88

320

2333

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

517

3732

1.42

12.17

3.8

5.12

5.15

kpa

0.33

492

3579

(3009343) pH of Capillary blood

503

3620

1.42

12.04

3.8

7.42

0.38

432

2989

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

175

2.99

12.02

1.1

—

(4062490) Immunoglobulin typing, IgG

116

568

2.06

11.99

1.8

1.3

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

450

2.20

11.95

1.2

103.01

107.60

pmol/l

0.40

450

(3003327) Ova and parasites identified in Stool by Light microscopy

286

1837

1.58

11.90

1.7

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

4.53

11.87

1.1

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

178

1010

1.79

11.83

1.3

66.67

242.22

titre

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

116

3.46

11.78

1.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

143

759

1.91

11.76

7.5

6.2

11.73

11.97

mg/l

0.27

129

707

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

215

1293

1.69

11.64

1.3

1.12

4.38

u/ml

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

4.59

11.63

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

212

1274

1.69

11.51

1.5

1.4

—

(4024509) Urine culture

371

2543

1.49

11.46

2.2

1.9

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

205

1223

1.70

11.44

3.1

1.8

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

246

1541

1.62

11.37

1.3

6.56

3.08

u/ml

0.42

147

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

288

1873

1.56

11.36

3.0

0.31

0.34

iu/ml

0.65

160

1044

(3027008) Opiates [Presence] in Urine

297

1947

1.55

11.31

3.1

2.1

—

(3028300) Cannabinoids [Presence] in Urine

298

1957

1.55

11.27

3.9

2.2

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

297

2.44

11.26

3.2

2.6

43.53

39.79

0.77

164

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

175

1009

1.76

11.04

1.3

346.67

379.00

titre

0.05

(3027944) Amphetamines [Presence] in Urine

293

1926

1.55

11.03

4.0

2.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

271

2.49

10.94

1.1

1.2

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

111

555

2.02

10.88

1.2

1.1

1.48

2.53

iu/ml

—

(3034770) Mitochondria Ab [Titer] in Serum

246

1561

1.60

10.80

1.2

818.00

1019.07

titre

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

194

1161

1.69

10.72

1.6

—

(21494814) CD8 cells/Lymphocytes in Specimen

217

2.64

10.54

2.0

29.04

30.79

0.35

217

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

304

2036

1.52

10.52

2.2

2.4

0.64

0.87

g/l

0.69

270

1754

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

265

1727

1.56

10.39

2.1

2.2

0.04

0.03

g/l

0.17

246

1555

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

310

2.34

10.28

1.3

1.5

5.26

6.85

u/l

1.23

271

(3029634) Reagin Ab [Titer] in Serum by VDRL

132

715

1.87

10.26

1.9

2.1

4.00

4.13

titre

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

239

1533

1.58

10.05

1.4

1.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

244

1574

1.57

10.01

1.2

1.3

108.42

118.17

titre

0.12

142

(4198724) Urine methamphetamine measurement

208

2.61

9.78

7.3

3.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

311

2126

1.49

9.77

2.3

2.0

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

375

2658

1.44

9.77

1.7

1.60

1.54

g/l

0.48

313

2299

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

121

648

1.89

9.76

1.4

1.3

—

nmol/l

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

227

1449

1.59

9.75

1.4

11.60

10.28

u/l

0.56

176

1178

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

581

4440

1.34

9.62

4.0

4.1

1.22

1.23

mmol/l

2.40

526

3849

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

107

554

1.95

9.56

1.8

1.7

479.87

355.96

mu/l

1.09

431

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

225

1442

1.58

9.51

1.6

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

179

1085

1.67

9.48

1.5

1.4

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

266

2.38

9.43

1.3

1.2

162.12

326.02

u/l

2.31

246

(1761868) Lipid panel - Serum or Plasma

1752

19894

0.83

9.25

3.6

3.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

397

5400

0.72

9.23

1.9

2.0

3.51

3.48

ratio

0.21

297

4139

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

175

1063

1.67

9.20

1.2

1.3

259.28

268.21

u/ml

0.15

104

661

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

136

774

1.77

9.05

1.4

1.3

0.43

0.27

nmol/l

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

427

2.05

9.05

1.1

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

407

2.08

9.04

1.1

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

580

4472

1.33

9.03

2.6

2.3

12.36

12.98

nmol/l

1.06

524

4015

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

428

2.05

8.99

1.1

1.2

—

(3011985) Renin [Units/volume] in Plasma

138

792

1.76

8.93

1.8

1.4

65.47

65.34

mu/l

0.00

129

705

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

708

5620

1.29

8.92

3.9

3.5

—

(3008898) HLA-B27 [Presence]

264

1780

1.51

8.90

1.1

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

444

2.02

8.86

1.1

1.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

177

1091

1.64

8.81

1.4

—

(3045716) Anion gap in Serum or Plasma by calculation

112

607

1.86

8.75

3.7

3.1

10.22

10.75

mmol/l

0.75

107

599

(3018333) Ribosomal P Ab [Presence] in Serum

399

2.07

8.74

1.1

1.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

183

1140

1.62

8.73

1.2

1.3

—

47.65

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

247

1651

1.52

8.68

1.3

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

434

2.02

8.67

1.1

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1961

17393

1.19

8.63

5.8

5.6

3.58

3.23

ug/l

0.13

1743

15760

(3003181) Sodium [Moles/volume] in Urine

173

1072

1.63

8.45

1.5

1.4

70.23

62.08

mmol/l

1.46

146

863

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

233

1550

1.52

8.39

2.2

2.3

0.00

g/l

-0.00

222

1458

(3037756) Immunofixation for Serum or Plasma

185

1170

1.60

8.32

1.5

1.6

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

375

2.07

8.21

1.1

15.24

9.76

iu/ml

0.52

107

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

246

1665

1.50

8.17

2.2

0.00

g/l

0.50

222

1459

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

343

2.11

8.14

1.5

1.6

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

4.36

8.14

1.2

1.80

1.70

umol/24h

0.20

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

116

651

1.80

8.13

1.4

1.3

0.17

0.21

nmol/l

0.91

101

517

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

758

6138

1.27

8.12

9.3

7.0

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

384

2.04

8.09

1.3

0.68

1.51

u/ml

0.71

221

(3051611) Lipemic interference index of Serum or Plasma

516

1.89

8.06

3.4

3.3

14.84

12.67

index

0.61

290

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

419

1.99

8.04

1.1

1.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

248

1688

1.49

8.02

1.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

627

4968

1.29

7.99

2.2

2.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

274

2.24

7.98

5.8

2.9

—

(3004809) Band form neutrophils/Leukocytes in Blood

150

910

1.66

7.98

4.2

3.7

1.28

1.65

0.71

131

813

(3028433) Virus identified in Specimen by Culture

165

2.62

7.92

1.0

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

174

1099

1.60

7.89

1.5

1.4

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

127

739

1.73

7.88

1.4

1.3

342.99

302.63

pmol/l

0.60

106

624

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.94

7.87

1.0

1.1

—

(3008037) Lactate [Moles/volume] in Venous blood

208

1372

1.53

7.81

4.3

3.1

1.51

1.61

mmol/l

1.05

202

1330

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

227

2.35

7.75

1.2

1.1

14.17

19.64

u/ml

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

121

698

1.75

7.75

1.4

25.42

28.05

u/l

0.38

103

568

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

4511

43038

1.19

7.72

32.8

20.9

331.63

332.19

g/l

3.82

4494

42783

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

259

2.25

7.71

1.6

5.02

8.98

nmol/l

0.51

208

(3024891) Influenza virus A+B Ag [Presence] in Specimen

202

1328

1.54

7.71

1.2

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

6.35

7.69

1.1

1.0

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

210

1396

1.52

7.62

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

677

5451

1.27

7.59

2.3

2.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

506

1.87

7.56

1.1

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

152

946

1.62

7.35

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

157

986

1.61

7.32

1.4

1.5

155.22

152.94

au/ml

0.08

281

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

276

1954

1.43

7.30

3.8

3.9

24.66

24.91

mmol/l

0.84

247

1787

(3035933) Granulocytes/Leukocytes in Blood

184

1201

1.55

7.27

3.8

3.4

58.36

58.21

0.06

184

1201

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

207

1388

1.51

7.23

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

209

1405

1.51

7.21

1.2

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.48

7.17

1.0

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

4.48

7.17

1.1

2.06

1.49

iu/ml

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

122

723

1.70

7.13

1.2

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

175

2.47

7.06

1.1

1.2

0.31

0.30

g/l

0.33

139

(3013005) Retinol [Moles/volume] in Serum or Plasma

244

2.22

7.02

1.6

1.8

2.27

1.95

umol/l

1.76

224

(3025018) Bordetella pertussis Ab [Titer] in Serum

350

2.01

7.01

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

598

4789

1.28

7.00

1.7

1.8

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

298

2.09

6.91

1.0

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

120

717

1.69

6.82

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

141

879

1.62

6.80

1.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

327

2418

1.37

6.74

1.5

1.4

28.01

27.49

iu/l

0.10

268

2075

(44790049) Parainfluenza type 3 nucleic acid detection

119

712

1.68

6.74

1.7

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

119

712

1.68

6.74

1.7

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

119

712

1.68

6.74

1.7

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

119

712

1.68

6.74

1.7

1.4

—

(4035726) Immunohistochemistry procedure

602

4848

1.27

6.74

1.5

1.4

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

295

2.08

6.70

1.1

1.07

1.06

ratio

0.29

232

(3024522) Salmonella sp identified in Specimen by Organism specific culture

118

707

1.68

6.65

1.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

147

934

1.59

6.57

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

770

6394

1.23

6.57

5.5

4.9

32.75

32.48

0.27

555

4230

(3013139) Helicobacter pylori Ag [Presence] in Stool

468

3665

1.30

6.53

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

117

705

1.67

6.47

1.4

—

(3022313) Gas panel - Capillary blood

335

2504

1.36

6.47

4.1

3.9

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

124

2.67

6.39

1.8

1.4

0.12

0.29

mmol/l

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

328

1.99

6.39

1.7

1.4

21.56

24.13

umol/l

0.30

304

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

113

679

1.68

6.32

1.5

1.4

—

(3012501) Base excess in Blood by calculation

173

1153

1.52

6.27

3.6

4.3

2.07

2.60

mmol/l

2.45

121

778

(3027923) C peptide [Moles/volume] in Serum or Plasma

303

2.02

6.27

1.5

1.4

1.16

1.24

nmol/l

0.20

216

(3006922) Hepatitis E virus Ab [Presence] in Serum

436

1.85

6.26

1.1

—

(3011897) Casein IgE Ab [Units/volume] in Serum

3.25

6.26

1.0

1.2

0.01

7.20

u/ml

0.52

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

354

2682

1.34

6.26

2.3

2.0

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

113

682

1.67

6.23

1.5

1.4

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

296

3959

0.73

6.19

1.7

3.34

3.46

mmol/l

1.03

198

2716

(3025468) Yersinia sp identified in Specimen by Organism specific culture

112

676

1.67

6.17

1.5

1.4

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.91

6.14

1.2

1.1

0.74

0.71

umol/24h

0.13

(3028679) Herpes simplex virus Ab [Presence] in Serum

279

2.05

6.10

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

110

2.74

6.10

1.6

2.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

580

1.72

6.09

1.2

47.20

41.96

u/ml

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

383

1.89

6.09

1.1

1.0

—

0.62

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

153

1003

1.54

6.00

1.6

1.7

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.34

5.99

1.7

2.0

—

(3017354) Segmented neutrophils/Leukocytes in Blood

100

591

1.70

5.97

4.9

3.6

58.28

56.53

0.31

506

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

360

2755

1.33

5.96

1.1

1.0

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

394

1.86

5.92

1.3

1.5

11.91

12.94

umol/l

0.72

369

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

373

1.89

5.90

1.0

32.66

42.43

ng/l

1.89

259

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.40

5.85

1.1

—

(3025130) Human papilloma virus identified in Specimen

118

734

1.62

5.81

1.8

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

3.07

5.75

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

341

1.92

5.75

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1562

13967

1.16

5.75

4.7

4.6

22.02

22.01

0.00

729

6989

(3037121) Protein [Mass/volume] in Urine

255

1864

1.38

5.69

3.5

3.2

488.88

371.99

mg/l

0.22

117

825

(3002256) Pathology report gross observation

857

7294

1.20

5.69

1.3

—

(3022621) pH of Urine by Test strip

538

4363

1.26

5.69

3.2

2.7

6.08

0.03

349

2986

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

114

707

1.62

5.69

1.1

1.07

2.96

1.62

113

(40768443) Skin Pathology biopsy report

322

2442

1.34

5.68

1.2

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

134

864

1.56

5.68

1.2

1.1

16.70

17.58

au/ml

0.06

203

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

371

1.87

5.67

1.0

729.84

736.30

ng/l

0.03

255

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

410

3218

1.29

5.65

2.5

2.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

344

1.90

5.61

1.2

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

164

2.33

5.56

1.2

1.4

139.98

126.21

nmol/l

0.19

118

(3003694) ABO and Rh group [Type] in Blood

1701

15342

1.15

5.52

1.5

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

172

2.28

5.44

1.0

1.1

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

464

1.76

5.44

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

464

1.76

5.44

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

464

1.76

5.44

1.7

—

(3026389) Candida sp identified in Specimen by Organism specific culture

121

771

1.58

5.42

1.5

1.4

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

696

5839

1.22

5.36

3.5

4.3

62.24

21.11

ug/l

0.73

569

4760

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

175

1210

1.46

5.35

2.2

1.8

195.25

205.13

pmol/l

0.66

166

1138

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

190

1335

1.44

5.34

1.1

5.89

7.20

eliau/ml

0.12

164

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

182

2.21

5.20

1.5

2.2

134878.57

17217.33

u/ml

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

221

1603

1.39

5.20

1.9

1.8

42.61

42.11

nmol/l

0.12

215

1552

(3038515) Glucose [Moles/volume] in Venous blood

165

1138

1.46

5.13

4.5

3.2

7.40

7.58

mmol/l

0.32

160

1104

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

111

1702

0.65

5.00

1.1

0.61

0.63

ratio

0.09

219

(3017704) Immunofixation for Urine

280

1.94

5.00

1.5

1.6

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

469

1.72

4.99

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

555

1.65

4.91

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

101

634

1.60

4.86

1.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

443

1.72

4.85

1.2

197.69

172.53

titre

0.10

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

257

1.95

4.76

1.4

3.90

4.79

umol/l

1.12

228

(3016038) Potassium [Moles/volume] in Urine

401

1.75

4.75

1.2

32.45

35.57

mmol/l

0.58

356

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

372

1.78

4.73

1.0

470.82

320.61

ng/l

0.33

262

(21494755) Public health laboratory ask at order entry panel

351

4416

0.78

4.73

1.3

1.4

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

145

994

1.47

4.69

1.3

35.02

39.17

u/l

0.09

125

862

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

533

4417

1.23

4.65

2.9

2.7

67.39

65.79

ml/min/173m2

0.46

239

1876

(4015189) Microbial culture of sputum

127

2.37

4.64

1.8

2.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

198

2.08

4.63

1.2

—

(40757494) Bilirubin.total [Moles/volume] in Blood

274

1.91

4.62

1.9

2.4

21.74

22.20

umol/l

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

4.29

4.62

1.0

—

(3034426) Prothrombin time (PT)

172

2.16

4.61

1.2

1.3

28.57

28.46

0.03

172

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

112

730

1.54

4.61

1.6

—

(4094501) Cardiovascular stress test using bicycle ergometer

201

1470

1.38

4.55

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

141

2.28

4.53

1.4

1.5

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

276

1.89

4.53

1.1

1.2

—

(3002079) Sodium [Moles/time] in 24 hour Urine

245

1.93

4.33

1.3

183.74

164.82

mmol/24h

0.65

245

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

898

7855

1.17

4.31

1.5

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

111

736

1.52

4.25

1.5

1.6

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

549

1.59

4.15

4.1

3.8

—

(3044242) Glucose [Moles/volume] in Arterial blood

321

1.78

4.15

2.7

2.1

7.84

8.09

mmol/l

0.17

321

(42529582) MDA5 Ab [Presence] in Serum by Line blot

155

2.14

4.04

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

155

2.14

4.04

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

155

2.14

4.04

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

155

2.14

4.04

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

414

1.67

4.03

3.8

2.6

29.27

31.73

mg/l

0.18

297

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

354

1.73

4.02

1.3

—

(3016031) Almond IgE Ab [Units/volume] in Serum

4.20

4.00

1.0

0.14

0.48

u/ml

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

4.20

4.00

1.0

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

362

1.72

4.00

1.3

—

(3008295) Osmolality of Serum or Plasma

635

1.54

3.97

1.5

1.4

281.49

277.55

mosm/kgh2o

0.84

493

(1616796) Gas panel - Central venous blood

175

1285

1.37

3.92

3.3

3.9

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

152

1092

1.40

3.88

3.5

1.8

0.88

0.86

nmol/l

0.08

129

930

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

2.77

3.85

2.7

1.2

77.90

47.48

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

146

2.13

3.79

1.7

1.9

16.97

53.28

u/l

1.39

139

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

129

1811

0.71

3.76

1.1

1.52

1.53

g/l

0.13

129

1811

(3004451) EKG impression Narrative

317

1.74

3.74

1.4

1.3

—

(3004616) Nuclear Ab [Presence] in Serum

103

693

1.49

3.73

1.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

184

1379

1.34

3.64

2.2

2.3

128.66

128.72

g/l

0.01

146

1085

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

116

2.25

3.63

1.2

1.4

1.21

1.17

mmol/l

1.26

116

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

343

1.70

3.61

2.3

1.8

105.64

114.14

ng/l

0.22

343

(3000330) Specific gravity of Urine by Test strip

343

2791

1.24

3.61

4.5

3.3

1.02

ratio

0.03

309

2515

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

506

1.57

3.59

3.3

2.9

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

277

1.78

3.57

1.1

1.2

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

191

1.94

3.56

1.3

1.5

14.89

16.04

pmol/l

0.51

164

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

164

1212

1.36

3.56

1.6

1.5

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

208

1593

1.32

3.56

1.4

1.3

179.12

221.07

miu/ml

1.08

728

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

429

1.62

3.55

1.3

8.17

9.12

mmol/l

1.18

411

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

7.79

3.55

1.3

1.0

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

303

2439

1.26

3.52

1.3

1.4

—

(1002224) Polysomnography panel

300

2413

1.26

3.51

1.1

—

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

4.24

3.50

3.3

1.3

12.33

40.13

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

341

1.68

3.42

1.1

19.40

18.06

u/ml

0.14

146

(3020911) Cortisol [Moles/time] in 24 hour Urine

187

1.93

3.42

1.3

1.4

132.31

304.89

nmol/24h

0.53

187

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

2.98

3.41

2.1

1.36

1.39

mg/l

0.02

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

427

1.60

3.38

1.5

1.6

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

313

1.70

3.34

1.2

1.1

82.51

82.68

u/l

0.01

280

(3042111) Morphology [Interpretation] in Bone marrow Narrative

135

980

1.39

3.30

1.7

1.6

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

3.64

3.28

1.2

1.1

—

(3044927) Protein electrophoresis panel - Urine

526

1.53

3.28

1.3

1.2

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

8.58

3.26

1.0

1.1

1.87

1.40

mg/l

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

323

1.68

3.26

1.6

1.5

4.66

6.80

u/l

0.72

256

(3033099) Centromere Ab [Titer] in Serum

122

2.14

3.25

1.2

1.1

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

2.50

3.20

1.7

1.6

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

310

1.68

3.18

1.2

1.1

21.95

25.08

u/l

0.22

277

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

193

1.87

3.14

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

267

1.73

3.11

1.7

2.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

267

1.73

3.11

1.7

2.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

267

1.73

3.11

1.7

2.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

267

1.73

3.11

1.7

2.0

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

647

1.46

3.11

1.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

103

722

1.43

3.09

2.0

2.4

0.95

1.30

g/24h

1.05

431

(3006462) Nitrate [Presence] in Urine

246

1.75

3.06

3.8

3.5

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

2.68

3.05

1.1

1.0

0.00

0.05

u/ml

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

153

1.97

3.03

1.3

1.2

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

3.34

3.01

1.6

1.4

0.93

2.18

mg/l

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

497

1.52

2.99

1.3

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

4.29

2.99

4.4

5.3

—

(40761536) Microorganisms panel - Urine sediment

506

4358

1.18

2.98

4.9

4.0

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

161

1.93

2.98

1.2

8.25

11.91

pmol/l

—

(3036005) Urine sediment comments by Light microscopy Narrative

10.01

2.98

1.0

1.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.54

2.95

1.6

1.5

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

3.25

2.93

1.6

1.4

0.60

1.40

mg/l

—

(21494890) Protein electrophoresis panel - 24 hour Urine

566

1.47

2.90

2.5

2.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

108

2.13

2.90

1.1

1.4

—

(3028717) Thiamine [Mass/volume] in Blood

2.37

2.88

1.3

1.2

59.00

64.63

ug/l

0.58

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

567

1.47

2.88

1.6

1.3

1.74

1.55

nmol/l

0.52

513

(3012920) Ethanol [Mass/volume] in Serum or Plasma

6.67

2.86

1.3

1.8

1.42

2.30

g/l

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

192

1504

1.29

2.85

1.4

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

129

2.02

2.85

1.2

1.1

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

618

1.45

2.84

1.3

1.6

53.47

59.44

0.57

390

(3008757) Leukocyte morphology finding [Identifier] in Blood

536

1.48

2.84

5.4

4.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

170

1315

1.30

2.79

1.4

1.6

—

(3006270) Folate [Moles/volume] in Blood

425

1.54

2.78

1.2

1.1

332.27

364.16

nmol/l

0.71

369

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

212

1688

1.27

2.77

3.5

3.6

1.51

1.56

mg/l

0.40

186

1540

(3043410) Blood group antigens tested for on Red Blood Cells

138

1.96

2.74

2.0

1.9

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

181

1.83

2.72

4.6

2.9

4.84

4.88

kpa

0.10

181

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

115

843

1.37

2.72

1.1

130.39

13644.63

iu/ml

0.53

172

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

253

2062

1.24

2.70

2.9

3.6

716.41

2833.83

u/ml

0.85

216

1784

(3023419) Bacteria identified in Sputum by Culture

100

721

1.39

2.62

2.9

2.6

—

(3040151) Glucose [Moles/volume] in Capillary blood

640

1.41

2.56

12.4

16.0

7.60

7.22

mmol/l

0.23

542

(40765096) Chromosome analysis panel by Banding

178

1.80

2.55

1.3

1.1

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

2.73

2.54

2.2

1.9

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

105

769

1.37

2.52

1.1

1.52

g/l

0.03

100

701

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

592

1.42

2.52

2.4

24.04

31.77

iu/ml

0.50

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

2.32

2.48

1.2

1.3

234.63

79.58

ng/l

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

321

2710

1.19

2.44

3.1

3.6

70.42

66.96

u/ml

0.05

313

2609

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.55

2.44

1.0

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

546

1.43

2.44

1.3

1.2

52.64

63.94

u/l

1.29

480

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

181

1.77

2.42

4.7

2.9

10.07

10.13

kpa

0.05

181

(3017569) Oxygen content in Arterial blood

336

1.55

2.39

1.9

2.3

16.16

16.21

0.04

336

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

451

1.47

2.35

1.3

1.6

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

118

1.95

2.34

1.3

1.1

—

(4146454) Self-monitoring of blood glucose

584

1.41

2.34

3.2

2.7

—

(4211845) Urine protein measurement

268

1.61

2.31

3.8

3.3

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.46

2.27

1.0

—

(3000475) Leukocytes [#/volume] in Synovial fluid

174

1392

1.26

2.25

1.6

13104.78

12093.96

e6/l

0.14

132

969

(3042631) Mycobacterium sp identified in Specimen

727

1.35

2.21

2.6

2.9

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.41

2.19

1.2

1.1

0.02

0.03

u/ml

0.95

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

210

1.67

2.19

1.0

1.1

99.67

93.49

0.34

161

(3037692) Legionella sp identified in Specimen by Organism specific culture

180

1.73

2.18

1.5

—

(3000093) Morphology [Interpretation] in Blood Narrative

517

1.42

2.18

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

249

1.61

2.18

3.5

3.1

1.52

1.34

0.28

249

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

118

903

1.31

2.17

1.8

1.7

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

196

1.69

2.15

1.8

2.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

196

1.69

2.15

1.8

2.2

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

419

1.46

2.14

1.4

1.6

19.60

24.00

u/ml

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

589

1.38

2.09

2.2

4.76

7.01

umol/l

2.15

431

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

168

1.73

2.07

1.2

1.1

94.38

87.85

0.70

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

246

1.59

2.03

1.2

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

246

1.59

2.03

1.2

1.4

—

(3048879) Bone marrow aspiration report

147

1.77

2.02

1.8

2.1

—

2.00

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

517

1.40

2.01

1.3

1.4

194157.44

121433.37

e6/l

0.24

350

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

152

1221

1.25

1.94

2.7

3.5

151.13

791.99

u/ml

1.79

138

1107

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

164

1.71

1.94

1.1

—

(3051339) Copper [Moles/volume] in Blood

2.97

1.93

1.1

1.2

16.18

16.91

umol/l

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

3.75

1.93

1.0

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

203

1.63

1.91

2.7

2.8

0.63

0.61

mmol/l

0.97

203

(3052592) Norovirus Ag [Presence] in Stool

1.92

1.90

1.4

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

3.18

1.88

1.9

3.2

—

(37208534) Antinuclear antibody arbitrary concentration in serum

166

1.69

1.87

1.0

1.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

508

1.38

1.86

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

252

1.55

1.86

2.2

2.3

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

197

1.63

1.86

1.9

2.2

—

(3005570) Glucose [Moles/volume] in Urine

534

1.37

1.85

2.4

2.0

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

2.03

1.85

1.2

1.1

6.13

7.71

u/ml

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

144

1.74

1.84

1.1

1.2

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

3.53

1.83

1.0

1.3

—

mmol/l

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

3.53

1.83

1.0

1.1

—

(3007463) Buprenorphine [Presence] in Urine

3.05

1.80

3.9

5.2

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

3.05

1.80

1.1

1.4

284.91

405.33

nmol/l

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

479

1.38

1.77

1.2

1.5

26.36

30.44

0.33

296

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

109

1.84

1.76

1.4

1.2

116.40

78.46

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

216

1.58

1.76

1.2

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

2.22

1.73

1.2

1.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

381

1.42

1.71

1.4

1.5

—

(44806071) Cardiolipin IgM antibody measurement

2.06

1.70

1.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

301

1.47

1.64

1.4

1.2

30.25

24.78

u/l

0.17

247

(3032057) Clostridioides difficile [Presence] in Stool

105

1.81

1.62

1.4

2.0

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

352

1.42

1.62

1.4

1.5

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.07

1.59

1.2

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.07

1.59

1.1

1.3

—

(3020491) Glucose [Moles/volume] in Blood

387

1.40

1.59

2.0

2.2

8.09

6.57

mmol/l

1.75

267

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1084

0.77

1.59

1.4

1.5

—

(3003740) Influenza virus B Ag [Presence] in Specimen

111

886

1.26

1.56

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

122

1.72

1.54

1.3

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

314

1.44

1.54

1.4

1.2

92.05

88.62

u/l

0.08

263

(3041672) Baker's yeast Ab [Presence] in Serum

2.43

1.53

1.1

—

(4034850) Laboratory test

191

1617

1.19

1.52

9.2

10.3

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

169

1.60

1.51

1.3

1.2

86.42

87.74

0.05

(3020356) Listeria sp identified in Specimen by Organism specific culture

2.59

1.51

1.0

1.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

185

1.57

1.51

1.4

1.9

8652.67

19361.05

e6/l

0.43

(40768446) Kidney Pathology biopsy report

209

1.53

1.50

1.6

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

139

1144

1.22

1.49

3.5

3.3

0.74

0.82

nmol/l

2.25

114

918

(3003888) Timothy IgE Ab [Units/volume] in Serum

114

921

1.24

1.46

1.1

3.24

5.09

u/ml

0.82

483

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.37

1.45

1.7

1.2

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

260

1.46

1.45

2.2

2.0

43.80

196.57

ug/min

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

160

1340

1.20

1.45

1.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

175

2062

0.84

1.43

1.6

1015.25

1007.57

mu/l

0.03

136

1720

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.97

1.43

1.4

1.6

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

404

1.36

1.43

2.1

1.8

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1098

0.79

1.41

1.4

1.5

1.11

1.18

ratio

0.35

657

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1098

0.79

1.41

1.4

1.5

1.05

0.94

ratio

0.86

653

(3014271) Vancomycin [Susceptibility]

246

1.47

1.39

2.8

2.9

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1096

0.79

1.39

1.4

1.5

1.04

1.14

ratio

0.76

651

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

484

1.33

1.39

3.8

5.4

163.54

62.38

u/ml

0.75

146

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

2.08

1.38

1.2

1.4

97.32

119.23

ug/l

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.20

1.36

1.0

1.2

8.33

18.15

u/l

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

331

1.39

1.36

1.7

1.6

88.48

81.82

umol/l

0.26

331

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1170

0.80

1.36

1.5

57.13

59.50

ug/l

0.25

975

(3033086) Enterovirus Ab [Titer] in Serum

2.94

1.36

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

109

886

1.23

1.35

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

216

1.48

1.32

1.6

2.2

4719.00

796.09

e6/l

0.43

149

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1099

10376

1.07

1.32

3.2

3.3

0.74

0.78

ug/l

0.67

749

6911

(3010375) cycloSPORINE [Mass/volume] in Blood

241

1.45

1.32

24.6

26.8

126.69

113.74

ug/l

0.48

194

(3000012) Reticulocyte production index

103

835

1.24

1.31

2.0

2.2

1.00

0.87

1.16

562

(3019174) dRVVT (LA screen)

2.09

1.30

1.3

1.2

—

(3002619) Bacteria identified in Specimen by Culture

129

1.63

1.29

1.1

1.3

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

104

846

1.23

1.29

1.1

0.75

1.62

u/ml

1.10

419

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.78

1.28

1.2

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

2.78

1.28

1.0

1.1

0.70

0.86

u/ml

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

421

1.33

1.28

1.2

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

794

1.24

1.26

1.4

1.5

0.41

0.37

nmol/l

0.17

613

(3005033) Fetal Nuchal fold Thickness US

900

0.79

1.23

1.5

1.26

1.27

0.03

635

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.16

1.21

2.1

1.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

341

1.35

1.17

1.4

1.5

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

1.70

1.17

1.5

4.17

9.08

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

1.77

1.16

1.9

3.6

19.32

26.12

mg/l

—

(40758292) HTLV I+II Ab panel - Serum

102

1.67

1.16

1.1

1.4

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

107

886

1.21

1.15

1.1

1.00

1.06

u/ml

0.04

376

(3012494) Peanut IgE Ab [Units/volume] in Serum

126

1.59

1.14

1.1

0.88

1.65

u/ml

0.34

(3023430) Cat dander IgE Ab [Units/volume] in Serum

698

1.24

1.12

1.1

4.37

4.48

u/ml

0.02

304

(3036048) Francisella tularensis Ab [Titer] in Serum

127

1.58

1.11

1.0

1.1

—

568.00

—

(21494434) Karyotype in Bone marrow

503

1.28

1.10

1.2

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.26

1.10

1.0

—

(3045142) Bone marrow Pathology biopsy report

655

1.24

1.10

1.4

1.3

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

916

0.81

1.07

1.5

—

(40757373) Influenza virus identified in Isolate

105

1.62

1.05

1.7

1.6

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

105

1.62

1.05

1.7

1.4

—

(21491868) Cryoglobulin [Mass/volume] in Serum

195

1.44

1.04

1.1

1.2

—

0.21

g/l

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

1.67

1.03

7.1

7.5

10.62

10.29

0.28

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

733

1.22

1.03

2.2

32.80

32.50

0.28

728

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.27

1.03

1.4

1.1

0.02

0.05

u/ml

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

689

1.22

1.02

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

1.92

1.02

1.1

1.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.89

1.01

1.1

1.0

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

683

1.22

0.98

1.1

2.73

3.39

eliau/ml

0.26

311

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

550

0.76

0.98

1.4

1.3

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

512

1.25

0.98

1.2

1.4

—

(3024471) HLA-A [Type]

165

1.46

0.96

1.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

750

1.20

0.95

1.1

5.17

3.30

u/ml

0.36

367

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

125

1.52

0.93

1.6

2.3

3.47

288.66

ug/l

0.67

125

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

418

1.27

0.92

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

142

1.48

0.92

1.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

195

1733

1.13

0.91

1.5

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

939

0.83

0.90

1.5

1.6

—

(3044009) aPTT.lupus sensitive (LA screen)

1.91

0.88

1.4

1.2

—

(3001556) Androgen free Index in Serum or Plasma

1.91

0.88

1.3

1.1

—

(3017509) Phencyclidine [Presence] in Urine

1.91

0.88

4.1

1.6

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

161

1.43

0.86

1.9

1.7

9.93

8.71

ug/l

0.47

161

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

423

1.26

0.85

1.4

2.0

3.71

1.49

u/field

1.14

229

(44813793) Dust mix specific IgE antibody measurement

352

1.28

0.85

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.67

0.85

1.0

1.1

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

1.94

0.84

1.0

45.67

53.56

u/l

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

301

1.30

0.82

1.1

1.2

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.88

0.81

1.3

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

387

0.75

0.81

1.0

1.1

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

138

1.45

0.81

1.5

1.4

46.90

31.57

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

181

1.38

0.79

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.53

0.78

1.0

31.22

39.45

iu/ml

0.23

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

554

5223

1.07

0.76

1.5

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

219

1987

1.11

0.75

1.6

13.04

15.82

u/ml

0.26

449

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.70

0.75

1.0

1.1

—

(3044007) Cell count panel - Peritoneal fluid

192

1.36

0.74

1.7

2.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

143

1267

1.13

0.74

6.1

4.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

198

1789

1.11

0.74

1.7

5.11

4.47

mg/l

0.21

162

1331

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

606

1.19

0.73

1.6

1.5

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

2.00

0.72

1.2

1.6

37.10

27.43

nmol/l

—

(40762887) Creatinine [Moles/volume] in Blood

1.80

0.72

1.4

1.6

—

(3042733) HLA Ab [Presence] in Serum

176

1.37

0.72

3.9

4.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

118

1342

0.88

0.72

1.5

1.4

—

(3045462) Protein/Creatinine [Ratio] in Urine

1.67

0.72

2.4

3.7

74.17

41.78

mg/mmol

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

645

1.18

0.71

1.1

0.07

0.27

u/ml

2.50

209

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

1.75

0.71

1.1

1.2

—

41.19

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

1.92

0.70

1.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.92

0.70

1.2

1.5

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

309

1.26

0.70

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

160

1.38

0.70

1.1

1.2

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

212

1.32

0.70

1.4

1.5

68.73

64.65

0.28

174

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.60

0.68

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

222

1.31

0.68

1.1

1.0

—

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

614

0.83

0.65

3.7

3.0

13.32

13.17

0.44

608

(3035880) pH of Pleural fluid

313

1.25

0.64

1.3

1.4

7.39

7.40

0.23

214

(3038071) Oxygen [Partial pressure] in Mixed venous blood

120

1.42

0.64

7.0

7.6

5.05

5.39

kpa

0.37

120

(3022493) Free Hemoglobin [Mass/volume] in Plasma

233

1.29

0.64

4.0

3.4

80.73

68.25

mg/l

0.50

164

(3024932) HLA-DR beta [Type]

163

1.35

0.64

1.0

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

653

1.17

0.63

2.4

2.1

20.03

23.80

mg/l

0.29

230

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.52

0.62

4.0

5.9

—

2356.80

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.63

0.62

2.0

2.7

0.38

0.59

u/field

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

120

1070

1.12

0.60

1.2

1.1

0.71

2.22

u/ml

4.14

567

(3006969) Lambda light chains [Mass/volume] in Urine

0.00

0.60

0.0

1.0

—

0.14

—

(3036071) Salmonella sp Ab [Titer] in Serum

174

1.32

0.59

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

509

1.18

0.59

1.5

1.3

—

(3003434) Protein [Mass/volume] in Pleural fluid

827

1.14

0.59

1.4

1.5

32.24

32.12

g/l

0.03

752

(3035082) Kappa light chains [Mass/volume] in Urine

0.00

0.58

0.0

1.1

—

0.02

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

341

0.79

0.55

1.4

1.3

156.09

188.99

pmol/l

0.51

341

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.62

0.55

2.0

3.9

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

1.62

0.55

4.0

2.38

2.30

mg/l

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

136

1230

1.11

0.55

2.3

2.4

134.49

110.45

ug/min

0.16

735

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

213

1.27

0.53

1.0

1.1

2.77

6.77

u/ml

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

249

1.25

0.53

1.1

1.3

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

286

1.23

0.52

1.6

2.5

212.14

204.27

u/l

0.39

281

(40761539) Cells [Type] in Urine sediment by Light microscopy

126

1.35

0.51

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.41

0.51

1.0

—

(40768800) Prostate Pathology biopsy report

105

1168

0.90

0.50

1.1

1.2

—

(40762814) Titanium [Mass/volume] in Blood

1.47

0.50

2.0

2.4

3.32

3.97

ug/l

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.52

0.48

3.3

2.6

—

(40768441) Liver Pathology biopsy report

430

1.16

0.46

1.5

1.4

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.61

0.43

1.0

1.1

0.00

0.19

u/ml

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

996

0.90

0.42

1.5

1.6

—

(3027035) Albumin [Mass/time] in 24 hour Urine

1.40

0.42

1.4

1.3

—

640.53

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.52

0.41

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.52

0.41

1.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.40

0.0

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.47

0.40

1.0

1.2

—

(3022475) Manganese [Moles/volume] in Blood

1.47

0.40

1.0

1.4

0.15

0.16

umol/l

—

(3012441) Differential panel - Pleural fluid

615

1.12

0.40

1.5

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

103

1127

0.91

0.39

4.3

3.4

22.06

27.57

mg/l

0.93

771

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.36

0.38

1.1

1.3

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.33

0.37

1.1

1.3

—

(3047189) Immunofixation for 24 hour Urine

271

1.18

0.37

2.4

1.8

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.39

0.36

1.1

—

(40768793) Breast Pathology biopsy report

137

1275

1.08

0.35

1.3

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

117

1.28

0.35

2.1

2.2

6.57

7.76

mmol/l

—

(4133840) Spirometry

126

1.27

0.35

1.3

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

897

0.91

0.33

1.4

1.6

—

(3051101) Glucose [Moles/volume] in Cord blood

0.67

0.32

3.5

7.0

10.12

8.28

mmol/l

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

627

1.10

0.31

1.6

1.4

13558.20

69549.36

e6/l

3.11

353

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

428

1.12

0.30

1.2

1.3

13.83

13.05

u/l

0.12

392

(3012898) Urea [Moles/volume] in Urine

1.25

0.29

1.4

1.3

159.57

157.06

mmol/l

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

162

1535

1.06

0.27

1.4

1.5

—

(3045788) Cell count panel - Pleural fluid

585

1.10

0.27

1.7

1.5

—

(3023199) Leukocytes [#/volume] in Pleural fluid

713

1.08

0.25

1.6

1.5

2871.70

3400.01

e6/l

0.12

501

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.28

0.24

1.1

1.3

—

(3009871) Measles virus Ab [Titer] in Serum

189

1.16

0.24

1.6

3497.14

3397.65

titre

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

255

1.14

0.24

1.2

1.7

13.26

431.56

pmol/l

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

765

0.93

0.23

1.6

1.5

68.02

60.83

ug/l

0.52

765

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

257

1.13

0.22

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.22

0.22

2.8

1.5

295.20

347.78

umol/24h

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

144

1.18

0.22

1.3

1.4

21.20

24.75

g/l

0.45

110

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

273

0.88

0.21

1.8

1.5

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

0.00

0.21

0.0

1.0

—

(42528597) U1 small nuclear ribonucleoprotein C Ab [Presence] in Serum by Line blot

0.00

0.21

0.0

1.0

—

(3016135) IgD [Mass/volume] in Serum

0.00

0.21

0.0

1.3

—

43.88

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.21

0.0

1.0

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

305.60

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.21

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.21

0.0

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

0.00

0.21

0.0

1.0

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3034614) HLA Ag [Interpretation]

0.00

0.21

0.0

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

230

1.13

0.20

1.5

1.6

39.99

39.75

g/l

0.07

230

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.25

0.20

3.3

2.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

113

0.80

0.20

2.1

3.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

871

0.94

0.19

3.6

3.8

43.01

30.33

u/ml

0.37

845

(3020874) Milk IgE Ab [Units/volume] in Serum

298

1.11

0.19

1.2

1.1

0.19

2.41

u/ml

1.12

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.19

0.18

1.0

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

174

0.86

0.17

2.1

1.8

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

176

1.14

0.17

1.5

2.51

2.88

0.11

150

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

591

1.07

0.17

1.6

1.5

4.31

3.86

ug/l

0.09

516

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.11

0.17

1.3

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

660

0.94

0.17

1.3

7.92

7.31

mmol/l

0.66

580

(3034092) Cytoplasmic Ig cells/cells in Blood

1.18

0.16

9.3

10.4

0.24

0.20

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

120

1.17

0.16

1.1

1.2

—

(40768795) Lymph node Pathology biopsy report

554

1.07

0.16

1.2

—

(3014891) Appearance of Pleural fluid

0.79

0.15

1.7

1.6

—

(3000034) Microalbumin [Mass/volume] in Urine

498

1.06

0.14

2.5

3.1

24.22

47.69

mg/l

0.94

381

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

112

1.16

0.14

1.2

1.8

1.50

1.98

ug/l

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

118

0.85

0.14

1.0

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

285

1.09

0.14

1.1

1.0

0.48

3.42

u/ml

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

0.82

0.13

3.0

6.3

8.13

8.59

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.82

0.13

1.5

3.2

39.88

45.14

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

180

1.11

0.13

5.2

3.6

7.07

8.40

mg/l

0.50

148

(3024263) Appearance of Synovial fluid

296

1.08

0.13

1.2

1.7

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

210

1.10

0.12

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

318

1.07

0.11

5.7

7.1

3.28

131.39

ug/l

1.16

205

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.16

0.11

1.1

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.16

0.11

1.1

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.16

0.11

1.1

1.2

—

(3036670) Protein [Mass/volume] in Synovial fluid

163

1.10

0.10

1.4

1.2

44.81

38.64

g/l

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

311

0.93

0.10

1.6

8.13

7.96

mmol/l

0.17

299

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

270

1.07

0.10

4.0

4.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.14

0.10

3.6

2.7

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

1.14

0.10

1.6

3.9

—

0.00

estimate

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.11

0.09

1.0

6.2

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.11

0.09

2.2

2.6

0.76

0.66

ug/l

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

114

0.88

0.09

1.4

1.2

2.18

1.56

mmol/l

—

(3025577) Chromium [Mass/volume] in Blood

321

1.06

0.09

1.8

2.3

1.72

2.16

ug/l

0.78

270

(3011544) Albumin [Mass/volume] in Pleural fluid

1.05

0.08

1.3

1.2

17.45

16.87

g/l

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

253

1.07

0.08

1.1

1.0

0.20

1.61

u/ml

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

216

0.93

0.08

1.8

1.9

0.71

1.29

u/ml

—

(3041806) Other cells [#/volume] in Blood by Manual count

146

1.10

0.08

1.7

1.5

0.54

0.50

e9/l

0.36

146

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

0.84

0.07

14.5

12.7

5.00

5.66

mmol/l

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.80

0.07

1.5

1.6

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.05

0.07

1.8

1.7

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

0.88

0.06

1.9

2.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

243

2458

0.99

0.05

1.5

1.7

—

(3004775) Volume in Urine collected for unspecified duration

407

1.03

0.04

2.5

2.4

608.47

629.98

0.13

273

(40768806) Pleura Pathology biopsy report

622

0.98

0.03

1.5

1.6

—

(44806420) Estimation of glomerular filtration rate

567

0.99

0.01

2.5

2.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

294

1.02

0.00

1.2

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

294

1.02

0.00

1.2

1.5

—

(3020650) Glucose [Presence] in Urine

192

0.99

0.00

1.6

1.7

0.00

0.03

estimate

0.80

192

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

268

1.01

0.00

1.4

1.7

2.40

3.41

u/field

0.42

193

(3016750) Collection duration of Urine

302

0.99

0.00

2.1

2.3

488.74

494.72

min

0.19

224

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

875

0.99

0.00

1.7

1.8

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

276

1.01

0.00

1.5

1.3

5.63

5.85

mmol/l

0.62

264

(3038177) Helicobacter pylori Ab [Presence] in Serum

837

1.00

0.00

1.3

1.2

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

161

0.99

0.00

1.0

8.11

12.19

u/ml

—

110

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

249

1.00

0.00

1.3

1.2

11.32

9.67

mm/h

0.28

249

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

1.01

0.00

1.0

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

0.88

0.00

1.2

1.5

6.60

13.39

pmol/l

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

0.90

-0.00

1.9

2.2

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(4281824) Cell count and differential, peritoneal fluid

590

1.00

-0.00

1.2

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

37.17

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

6.6

—

0.21

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.1

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

1432.86

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.96

-0.00

1.0

1.2

5.94

5.99

mmol/l

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

0.98

-0.00

1.5

1.2

—

0.64

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.02

-0.00

1.0

1.1

96.00

88.82

titre

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

0.25

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

0.96

-0.00

1.6

41.00

45.58

umol/l

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.00

-0.00

1.2

1.4

—

Mortality – FinRegistry

↥

Association

Association between endpoint H7_DIPLOPIA and mortality.

Females

Parameter	HR [95% CI]	p-value
H7_DIPLOPIA	1.261 [1.14, 1.39]	< 0.001
Birth year	0.996 [0.99, 1.0]	0.297

During the follow-up period (1.1.1998 — 31.12.2019), 2368 out of 13939 females with H7_DIPLOPIA died.

Males

Parameter	HR [95% CI]	p-value
H7_DIPLOPIA	1.231 [1.11, 1.36]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.006

During the follow-up period (1.1.1998 — 31.12.2019), 2994 out of 13545 males with H7_DIPLOPIA died.

Mortality risk

Mortality risk for people of age

years, who have H7_DIPLOPIA.

N-year risk	Females	Males
1	0.156%	0.261%
5	0.883%	1.563%
10	2.033%	3.62%
15	3.659%	6.976%
20	6.374%	11.805%

Relationships between endpoints

↥

Index endpoint: H7_DIPLOPIA – Diplopia

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Diplopia

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints